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 ABSTRACT 
 
Influencing Kidney Health and Function in Young Female Rats  
Through Dietary Alterations 
  
Joseph C. Gigliotti 
 
The occurrence of kidney failure in the US has drastically increased over the past 
decade.  The decline in health associated with chronic kidney disease can be prevented if 
detected early in disease progression.  However, substantial damage has often occurred 
before detection of renal disease is possible.  Therefore, disease prevention (as in all 
diseases) is the optimal treatment.   
In regards to the kidneys, dietary habits can have a profound influence on the 
function and overall kidney health.  This is particularly evident in female rats due to their 
susceptibility to diet induced renal disease.  In female rats, the initiation of chronic 
kidney disease typically involves nephrocalcinosis (NC).  NC is characterized by 
increased renal calcium (Ca) content, and involves the pathological deposition of mineral 
deposits in renal tissue.  Fluctuations in dietary Ca and phosphorus (P) content are the 
major consideration in managing NC.  However, other dietary components can mediate 
the development and severity of this disease in rats. 
Based on our study results, the source of dietary protein and lipid can influence 
the development of NC in female rats.  Our initial study compared the nutritional quality 
of a novel protein source derived from krill to the milk protein, casein.  Rats fed krill 
protein concentrate (KPC) had lower kidney weights (P<0.001), lower kidney Ca content 
(P=0.002), and lower incidence of renal damage than rats fed casein based diets.  These 
changes occurred in the absence of fluctuating urinary mineral content, which is a major 
cause of NC.  Further analysis showed that KPC contained residual krill oil, which is rich 
in omega-3 polyunsaturated fatty acids (ω-3 PUFAs).  The next study involved isolation 
and characterization of krill oil.  Krill oil is a unique lipid with high (>65%) polar lipid 
content including phospholipids, whereas other dietary sources of ω-3 PUFAs were found 
to be predominately triacyglyceride.  In the final study, the characterized oils were added 
to casein-based diets and fed to female rats to determine if lipid content influences the 
development of NC.  While rats fed KPC appeared to be protected from NC, rats fed the 
high fat diet as krill oil were the only rats who developed NC.  The high inclusion of krill 
oil resulted in elevated dietary P content due to its high phospholipid content.  Aside from 
NC, the renal fatty acid content was influenced by the diet and lead to an apparent 
decrease in urinary prostaglandin production in all rats consuming the long-chain ω-3 
polyunsaturated fatty acids (ω-3 LCPUFAs) eicosapentaenoic (EPA) and 
docosahexaenoic acid (DHA).  The consumption of the different ω-3 PUFA sources also 
resulted in reduced activity of the proinflammatory transcription factor NFκB, and 
expression of the proinflammatory cyclooxygenase -2 (COX-II) and transforming growth 
factor-beta (TGF-β).  Despite these observed results, no differences were noted in serum 
measures of kidney function.  We concluded that changing the source of dietary protein 
and lipid can mediate renal health in female rats.  It appears that ω-3 PUFAs do not 
influence the nephrocalcigenic nature of casein.  However, providing dietary ω-3 PUFAs 
resulted in decreased renal inflammatory activity as compared to rats fed corn oil.  This 
 supports the benefit of ω-3 PUFA supplementation in reducing the onset of diseases 
caused by inflammatory processes, and suggests that different dietary sources of ω-
PUFAs vary in regards to biological activity.
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1.0. Literature Review 
1.1 The Biochemistry of Omega-3 Polyunsaturated Fatty Acids (ω-3 PUFAs)  
1.1.1 Essential Fatty Acids 
Mammalian hepatocytes and adipocytes are able to synthesize a variety of 
fatty acids, which serve primarily as a metabolic energy source.  However, α-
linolenic acid (ALA; 18:3ω-3) and linoleic acid (LA; 18:2ω-6) are two PUFAs 
which cannot be synthesized de novo.  Mammals do not have delta (Δ) 12 and 
Δ15 desaturases, therefore double bonds cannot be placed beyond the Δ9 carbon 
during fatty acid synthesis.  The double bonds found in LA are at carbons Δ9 and 
Δ12, and carbons Δ9, Δ12, and Δ15 in ALA.  Therefore, ALA and LA are termed 
essential fatty acids (EFAs) and must be obtained from the diet.   
Currently, it is recommended for women to consume ~1.1 and men ~1.6 
g/d of ALA.  LA requirements are ~ 12 g/d for women and ~17g/d for men [1].  
Rodent EFA recommendations consist of 1.2g LA/kg diet and 2g ALA/kg [2].  
However, these requirements were based on tissue ω-6 and ω-3 concentrations as 
opposed to tissue functionality.  Therefore, the recommendations for EFAs may 
change once the relationship between tissue fatty acid content and tissue function 
is better understood.       
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1.1.2 Conversion of EFAs to long-chain polyunsaturated fatty acids 
(LCPUFAs ) 
Despite being termed essential, little biological activity has been directly 
attributed to ALA and LA.  Instead, the essential fatty acids are elongated and 
desaturated to form their respective LCPUFAs.  The formation of LCPUFAs from 
EFAs involves a series of steps, which occur primarily at the endoplasmic 
reticulum of hepatocytes (Figure 1).   
The action of Δ6 desaturase is the committed step in EFA conversion to 
LCPUFAs [3].  Subsequent elongation and another desaturation by Δ5 desaturase 
results in the formation of arachadonic acid (AA; 20:4ω-6) from LA, and EPA 
(20:5ω-3) from ALA.  DHA (22:6ω-3) is formed from further metabolism of 
EPA, which includes: two elongation reactions, another desaturation by Δ6 
desaturase, and relocation to the peroxisome for a single round of β-oxidation [4].  
In mammalian tissues, AA predominates as the major ω-6 LCPUFA, while EPA 
and DHA are the primary ω-3 LCPUFAs [5].      
Despite the biological importance attributed to these LCPUFAs, the 
conversion of the ω-3 EFA ALA into EPA and DHA appears to be limited.  
Factors limiting this conversion include: competition and substrate specificity for 
common elongation and desaturation enzymes [6], preference for ALA as a 
metabolic fuel [7], and LCPUFA induced suppression of liver desaturase enzyme 
expression [8].  The competition between LA and ALA is supported by a study in 
females subjects provided formulas consisting of constant LA (4% total energy) 
and variable ALA content (0-16% of total energy).  The EPA content in 
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circulating lipid fractions increased from 0.2 to ~1.8% of total fatty acids with 
increasing ALA consumption.  Despite the increasing presence of ALA, 
numerical increases in plasma AA were still observed [9]  Previous studies in men 
have shown that the oxidation of fatty acids is influenced by both the length of the 
ingested fatty acid and degree of saturation.  By measuring the exhalation of 
13
CO2 in men fed radiolabeled fatty acids, it was determined that the preference 
for fatty acid oxidation is C12:0 > C18:3(ω-3) > 18:1t(ω-9) > 18:1c(ω-9) > 
18:2(ω-6) > 16:0 > 18:0 [10].  Increased oxidation of ALA explains why only 
15% of ALA is used to synthesize EPA and DHA in humans; with ALA derived 
DHA being undetectable in some studies [5, 11].  Similar results were found in 
rodent studies, suggesting that mammalian ω-3 LCPUFA synthesis is limited and 
should be obtained in the diet [12]. 
 
1.1.3 Dietary sources of ω-3 PUFAs 
Research and health claims have promoted increased consumption of 
PUFAs.  Plant oils are the richest source of the essential fatty acids LA and ALA, 
with flaxseed oil reported to be one of the richest sources of ALA [13].  However, 
the low mammalian de novo synthesis of the ω-3 LCPUFAs  EPA and DHA from 
ALA has led to the recommendation to increase dietary consumption of these 
LCPUFAs.   
Recently, it has been suggested that healthy individuals should consume 
400-500 mg ω-3 LCPUFAs per day to decrease the risk for mortality associated 
with cardiovascular disease.  This level of ω-3 LCPUFA intake can be achieved in 
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the diet by following the American Heart Association’s recommendation to 
consume two servings of fatty fish per week [14].  The recommended types of 
fish include tuna, salmon, and menhaden which are normally harvested from 
colder waters.  Fatty fish are high in the ω-3 LCPUFAs EPA and DHA because 
their diets consist of various marine algae and planktonic crustaceans such as 
algae and krill.  These planktonic organisms have a high capability for de novo ω-
3 LCPUFAs synthesis, and depletion of fish stocks and concern of heavy metal 
contamination have led to an interest in the nutritional value of krill and algae [15, 
16]. 
 
1.1.4 Cellular activities of LCPUFAs 
Despite the host of benefits associated with ω-3 LCPUFA consumption, 
the cellular mechanisms behind their biological effects are still not fully 
understood.  Originally, fatty acid trafficking was believed to be a relatively 
random and somewhat passive event.  Information discovered during the past two 
decades suggests that fatty acid metabolism and cellular activity is tightly 
regulated [17], and that PUFAs are crucial components in cellular biology.    
 
PUFAs and biological membranes 
Fatty acids are typically cycled through several cellular compartments 
upon acquisition.  The cellular fate of fatty acids depends on both the needs of the 
cell as well as the type of fatty acid present.  As mentioned above, the oxidation 
of fatty acids depends on the length and desaturation of the fatty acid.  However, 
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fatty acid oxidation typically accounts for less than 40% of detectable fatty acid 
utilization [10].  This suggests that storage as triglycerides and membrane 
incorporation are the major metabolic fates of dietary fatty acids.       
A clear response to changes in dietary LCPUFA content is the resultant 
influence it has on cellular membrane fatty acid composition.  While the saturated 
and monounsaturated fatty acid content of membranes remain constant 
(approximately 50 and 30%, respectively), the ω-6 and ω-3 PUFA content appears 
to be the most variable.  This has important implications in cellular biology, since 
membrane fatty acid content influences membrane physiochemistry and 
subsequent cellular functions [18, 19]. 
The fatty acid content of the membrane can have profound influence on 
cellular activity and tissue function.  A classic example for this interaction 
involves the activation of phospholipases.  While several forms of phospholipases 
exist, all perform the similar action of cleaving membrane phospholipids upon 
stimulation by intracellular calcium.  Phospholipase A2 specifically targets the sn-
2 position of membrane phospholipids, and results in the liberation of the AA or 
EPA that commonly resides there.  Therefore, changing the membrane ω-6 and ω-
3 PUFA content can influence which species of LCPUFA are released upon 
phospholipase activation.  The activation of phospholipase A2 during certain 
disease states suggests that liberated fatty acids play a key role in inflammatory 
processes [20].  
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The influence of PUFAs on NFκB activity  
During the past 15 years, it has become evident that fatty acids influence 
gene expression through mediating the activity of various transcription factors 
[21].  Most studies addressing the influence of PUFAs on transcription factor 
activity is focused on metabolic processes.  However, recent data suggests that 
PUFAs can also modulate the activity of transcription factors involved in 
inflammatory processes.   
Nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) is 
considered a key regulator of cell viability and inflammatory pathways.  Activated  
NFκB upregulates the expression of various proinflammatory proteins in various 
cell types [22].  Therefore, NFκB is considered a master regulator of the 
inflammatory response and is a common target for steroidal anti-inflammatory 
drugs [24, 24].   
Interestingly, fatty acids appear to play a role in NFκB activity.  DHA 
supplementation, but not EPA, resulted in 60% decrease in NFκB activity, 50% 
reduction in COX-II expression [25], and greater than 25% reduction in vascular 
cellular adhesion molecule-1 (VCAM-1) expression in cultured endothelial cells 
[26].  In contrast, cultured immune cells and adipocytes display an increased 
NFκB activity when cultured with AA or palmitate [27, 28].  Therefore, the 
cellular and biological response depends on the species of fatty acid present and 
supports the recommendation to increase ω-3 LCPUFA consumption. 
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PUFAs and eicosanoid synthesis 
As mentioned above, PUFAs influence the expression of COX-II through 
mediating NFκB activation.  The COX enzymes initiate the formation of 
prostaglandins, which are hormone like signaling compounds involved in virtually 
all aspects of physiology.     
AA is the typical substrate for prostaglandin production.  Activated 
phospholipase A2 can result in liberated AA or EPA, which provides substrates 
for COX (which is located on the endoplasmic reticulum and nuclear envelope).  
COX converts AA to prostaglandin H2 (PGH2), which is an intermediate in the 
production of the 2-series prostaglandins (PGE2, PGI2, TXA2, PGF2α etc.) by a 
respective synthase.  Once produced, prostaglandins mediate various 
physiological responses by binding to select 7-transmembrane domain, G-protein 
coupled receptors.  The physiological outcome is based upon the species of 
prostaglandin produced, as well as the nature of the prostaglandin receptor present 
on the target cells.  The species of prostaglandin produced depends on the 
LCPUFA used as a substrate.  The 2-series is derived from the ω-6 LCPUFA AA, 
while the 3-series of prostaglandins are derived from the ω-3 LCPUFA EPA.  The 
3- series of prostaglandins typically display different affinities for prostaglandin 
receptors as compared to the 2-series prostaglandins.  Therefore, different cellular 
and physiological responses may occur to similar prostaglandins that differ in 
species.  For example, PGE3 differed from PGE2 in inducing proliferation of 
cultured fibroblasts.  PGE2 resulted in fibroblast proliferation at 50ng/ml, while 
similar PGE3 concentrations resulted in no difference in cell number.  PGE3 also 
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resulted in decreased expression of proinflammatory protein expression in both 
fibroblasts and macrophages as composed to cells exposed to PGE2 [29].  
 
Conclusion 
LCPUFAs are important cellular compounds, as evident by the essential 
nature of their 18 carbon precursors.  The reduction in inflammatory transcription 
factor activity and prostaglandin production supports the importance of ω-3 
LCPUFAs in ameliorating inflammatory conditions.  However, it is unclear if 
LCPUFAs influence non-pathological processes.  Aside from mediating 
inflammatory processes, prostaglandins are involved in all aspects of physiology.  
For example, kidneys are heavily reliant on prostaglandin production while NFκB 
mediates several forms of renal disease.  Therefore, the dietary PUFA content 
may heavily influence renal physiology.  
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1.2 Renal Physiology  
In general, the kidneys are viewed solely as excretory organs.  While a 
major function of the kidneys is to filter wastes out of the circulation, the kidneys 
also play key roles in various physiological processes [30].   
 
1.2.1 Renal Anatomy and Vasculature 
The kidneys are bean shaped organs located between the 12
th
 thoracic and 
the third lumbar vertebrae in humans.  Each kidney (left and right) receives 
arterial blood from the descending aorta via the left or right renal artery, which 
enters the kidneys through the renal hilum (which is also the site of renal 
innervation).  Inside the kidney the renal artery undergoes a series of divisions to 
form the segmental, interlobular, arcuate, and intralobular arteries as well as the 
afferent and efferent arterioles.  The efferent arterioles further divide to form the 
peritubular capillaries and vesa recta, which adjoin to form venuoles and 
eventually merge to form the renal vein.         
 
1.2.2 The nephron  
The vasculature of the kidney provides necessary nutrients and gases to 
the surrounding tissue.  In addition, the primary functions of the kidney are 
accomplished within specialized regions of the renal vasculature, and include 
regulation of blood volume, waste content, pH, electrolyte and mineral 
concentrations, and nutrient concentrations.  By regulating these components of 
the blood, the kidneys are the primary organ responsible for maintaining a 
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constant composition of all extracellular fluids.  In humans, it has been estimated 
that ~1700 liters of fluid flow through the kidney each day.  
To accomplish this work load, each human kidney is composed of around 
1 million nephrons (2 million in total).  The nephron is composed of vascular and 
tubular portions which are involved in filtering the blood (Figure 2).  Healthy 
individuals have around 2 million nephrons; yet, only ~10% of this capacity is 
needed to support life.  Despite this large reserve capacity, millions of Americans 
suffer from inadequate renal function each year [31]. 
 
The structure and functions of the glomerulus 
 The primary structure of the nephron is the glomerulus.  The glomerulus 
includes a number of cells / tissues that together perform the filtering 
responsibility of the kidney (as well as other processes).  The glomerulus is 
composed of an afferent arteriole, Bowman’s capsule, tubular capillaries 
(including the vesa recta), podocytes, and mesangium (Figure 3).  Glomerular 
diseases (glomerulonephritis) are the primary cause of renal failure in the U.S., 
which suggests that this is a key structure in renal physiology [31]. 
The physiology of the glomerulus begins with the entry of blood into the 
glomerulus via the afferent arterioles.  The afferent arteriole branches to form a 
“knot” of capillaries, which are completely encased by a structure called 
Bowman’s capsule.  These capillaries are extremely “leaky” due to the presence 
of fenestrations, which are porous structures in the walls of the capillaries (Figure 
4).  Fenestrations allow approximately 20% of the fluid portion of blood (plasma) 
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to be forced out of the capillaries into Bowman’s capsule.   This filtered fluid is 
termed filtrate since this is the portion of blood that was filtered.  The remaining 
80% of the blood not filtered leaves the capillaries via the efferent arteriole, and 
branches to form capillaries which surround the rest of the nephron [30].   
The capillary structure inside Bowman’s capsule appears as a “knot” due 
to the presence of podocytes and the mesangium (Figure 3).  These components 
are considered pericapillary structures, since they are found amongst (mesangium) 
and/or physically attached to (podocytes) the capillaries.  The podocytes “coat” 
the capillaries and assist with the filtering process, whereas the mesangium is a 
complex tissue with an undefined role in renal physiology.  The mesangium is a 
matrix consisting of various collagens (and other structural components), the 
mesangial cells (which produce the matrix), and resident immune cells.  Although 
the role of the mesangium in renal physiology is not completely understood, 
mesangial expansion is a common finding in glomerular diseases [32].  Mesangial 
expansion results in interference of normal glomerular processes, and is termed 
glomerular scarring (or glomerulosclerosis) upon histological evaluation.   
Glomerular filtration occurs by only allowing a portion of the plasma to 
escape the capillaries and enter into Bowman’s space (Figures 3 and 4).  Normally 
the filtrate and blood have equal concentrations of small solutes such as organic 
nutrients and minerals, while the cell and protein content of the filtrate is 
negligible.  This suggests that large plasma components such as cells and albumin 
are unable to escape the capillary lumen.  Early research described that the 
glomerulus discriminates not only by size, but also by the charge of a molecule.  
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This filtering capacity appears to be largely mediated by the charge characteristics 
of the glomerular basement membrane.  Loss of charge discrimination has been 
associated with renal disease in animal models, resulting in proteinuria and 
deposition of immune complexes within the glomerulus [33].    
 
Reabsorption along the tubular portion of the nephron 
Upon exiting the glomerular capillaries, the plasma filtrate is now subject 
to the biochemical processes of the tubular portion of the nephron.  Small organic 
nutrients, such as glucose and amino acids, and minerals are as concentrated in 
the filtrate as found in the plasma.  With ~1700 liters of blood flowing through the 
kidney daily, deficiencies of these solutes would quickly arise if they were not 
reabsorbed in the kidneys.  Almost 100% of the sodium, glucose, amino acids, Ca, 
and water is reabsorbed from the filtrate by the kidneys.  Aside from nutrient 
reabsorption, the kidneys play a key role in the maintenance of the pH and 
electrolyte content of the blood.  Maintenance of these and other compounds can 
include reabsorptive and secretory processes, both of which are accomplished 
within the tubular portion of the nephron [30]. 
Upon leaving the glomerulus, the solute rich filtrate enters into the 
proximal convoluted tubule.  The proximal convoluted tubule is where the 
majority of the glucose and amino acids are reabsorbed along with a majority of 
the sodium, chloride, and water.  Reabsorption of glucose and amino acids is 
mediated by sodium-dependent cotransporters located on the apical membrane of 
the tubular epithelial cells.  The organic nutrient transported from the tubular 
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lumen into the epithelial cell along with sodium.  Since this process is continually 
occurring, the concentration of organic nutrients within the epithelial cell 
increases.  High concentrations drive the diffusion of these nutrients out of the 
epithelial cell and into the peritubular capillaries, which allow for reentry into the 
general circulation [30].   
 
Ca and P reabsorption 
The reabsorption of Ca and P also occurs predominately in the proximal 
tubule.  Tubular P is reabsorbed in a sodium dependent cotransport mechanism, 
while Ca reabsorption primarily occurs via paracellular pathway [48].  However, 
renal handling of Ca and P can also be influenced by hormonal signaling. 
The major hormones involved in Ca and P metabolism are parathyroid 
hormone, vitamin D, and calcitonin [30].  Generally, parathyroid hormone and 
vitamin D are involved in increasing serum Ca levels by influencing release of Ca 
and P from bone, increasing intestinal absorption of Ca, and decreasing urinary 
excretion of Ca.  Increased urinary reabsorption of Ca is mediated by parathyroid 
hormone induced increase in Ca channels in the distal nephron.  Due to the toxic 
effects of elevated serum P, parathyroid hormone also stimulates the urinary 
excretion of P to counteract the increase in serum P induced by bone resorption.  
Calcitonin, on the other hand, is released from the thyroid gland in the presence of 
high serum Ca.  The release of calcitonin triggers a general hypocalcemic 
response, which primarily involves decreased Ca release from bone.  
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After losing a large portion of the solutes (i.e. organic nutrients, Ca, P, 
etc.) in the proximal tubule, the remaining filtrate eventually descends from the 
cortex of the kidney (cortex includes the glomerulus and both the proximal and 
distal convoluted tubules) into the medullary tissue (medulla includes both the 
descending and ascending Loops of Henle and the collecting ducts).  As the 
filtrate leaves the proximal tubule, it descends into the medulla via the descending 
limb of the Loop of Henle.  The Loop of Henle has varying properties which 
contribute to the development and maintenance of the medullary characteristics.  
The descending limb is water permeable.  Therefore, water diffuses out of the 
tubular lumen in response to the loss of solutes within the proximal tubule.  The 
filtrate then continues through the ascending limb, where sodium-chloride is 
actively pumped out of the lumen and into the interstitial space and associated 
capillaries.  The increased interstitial salinity is the driving force for water 
reabsorption from the kidney tubules.  This provides an ability to regulate water 
excretion, which is a key function of the kidneys [30]. 
 
The Renin-Angiotensin-Aldosterone-System in Sodium and Water Reabsorption 
Variable hydration states occur daily; yet extracellular volume remains 
relatively constant.  This is accomplished by fluctuating the amount of water 
excreted or retained in urine.  When there is an excess of water (overhydrated), 
then water reabsorption in the kidney is minimized and results in increased 
urinary volume (diuresis).  The opposite occurs in states of dehydration, where the 
kidneys reabsorb water and urinary volume decreases (antidiuresis).  This process 
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is initiated and carried out within the nephron and is referred to as the renin-
angiotensin-aldosterone system (RAAS).  RAAS’s primary function is to maintain 
efficient blood flow through the kidney by modulating plasma hemodynamics 
[30]. 
The initiation of RAAS occurs with the juxtaglomerular apparatus, which 
is a structure composed of the afferent and efferent arterioles of the glomerulus 
and the ascending limb of Henle (Figure 5).  Within the juxtaglomerular apparatus 
are a set of specialized cells which respond to changes in extracellular fluid 
components by releasing the protease renin.  Angiotensinogen is continuously 
secreted by the liver and has little biological activity.  The activation of 
angiotensinogen involves proteolytic cleavage by renin to produce angiotensin I.  
This proteolytic cleavage is the rate limiting step in the activation of the RAAS.  
Once angiotensin I is formed, it is rapidly converted to angiotensin II in 
pulmonary capillaries by angiotensin converting enzyme.  The primary effects of 
angiotensin II include the secretion of aldosterone from the adrenal cortex, 
constriction of the efferent arterioles, and peripheral vasoconstriction.  Taken 
together, the goal of the RAAS is to increase fluid flow through the kidney by 
increasing Na resorption, and redirecting blood flow through the glomerulus.  The 
importance of the RAAS in whole body fluid content becomes evident when the 
mechanisms behind renin release are understood.         
In the vasculature portion of juxtaglomerular apparatus, specialized 
granule cells act as baroreceptors which respond to changes in blood pressure.  
These cells produce and store renin, which is secreted in response to a drop in 
16 
 
blood flow.  While renin is produced and secreted from the granule cells, other 
cells / tissues can also induce the secretion of renin.  Within the ascending limb of 
Henle, which is in close proximity to the granule cells, are a group of cells known 
as the macula densa (Figure 5).  While the granule cells were baroreceptors which 
were sensitive to changes in blood flow in the vasculature, the macula densa cells 
are sensitive to the NaCl content of the tubular fluid.  These chemoreceptive cells 
induce a release of renin from the granule cells in response to a drop in NaCl.  
The activation of the granule cells appears to be largely mediated by the 
production of prostaglandins by the stimulated macula densa.  Rats fed a salt 
restricted diet have higher renal COX-II expression, which occurred specifically 
in the macula densa [34].  Furthermore, cultured mouse granule cells had 
increased renin mRNA and renin secretion when cultured with PGI2 and PGE2 
[35].  Finally, neural stimulation can also induce the release of renin.  The granule 
cells are innervated by the sympathetic nerves.  The peripheral baroreceptors 
induce sympathetic nerve activity during hypotension, and results in an increase 
in renin excretion.  The association of renal blood flow, tubular NaCl content, and 
systemic hypotension further supports the importance of the kidney in 
maintaining and regulating both renal and peripheral blood flow.      
The distal portion of the nephron, starting with the ascending Loop of 
Henle, is water-impermeable.  Therefore, the increased salinity outside of the 
tubule generates an osmotic gradient that can be utilized to reabsorb more water 
from with filtrate.  In the presence of antidiuretic hormone (ADH), the distal 
portion becomes water permeable by the addition of aquaporins. This allows 
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water to leave the tubule due to the large interstitial sodium chloride concentration 
and reenter circulation via the peritubular capillaries / vesa recta.  Therefore, this 
region of the nephron is where variable water excretion is controlled. 
 
Tubular Secretion is Another Method to Remove Substances from the Blood 
At this stage, the filtrate has lost much of its osmolarity due to solute 
reabsorption,(in the proximal tubule) and a portion of its water content 
(descending Loop of Henle).  Another process begins in the distal convoluted 
tubule, and includes regulation of the unfiltered blood in the peritubular 
capillaries.  By the process of tubular secretion, unwanted substances can stil be 
removed despite not undergoing glomerular filtration.  The plasma present in the 
peritubular capillaries are closely associated with the nephron tubules, as 
indicated in the process of reabsorption.  In the distal tubule, plasma components 
such as potassium and protons can be pumped out of the capillaries and into the 
filtrate for excretion.  This occurs due to the location of specific channels in the 
distal tubule epithelial cells.  In the proximal tubule (where reabsorption occurs), 
the solutes were pumped into the cell and then diffused through channels located 
on the basolateral membrane facing the capillaries.  These substances diffuse back 
into the circulation; however, the channels for potassium and protons in the distal 
tubule are located on the apical membrane.  Therefore, potassium and protons 
secreted from the capillaries diffuse into the tubular lumen for excretion.  The 
secretion of protons and the presence of bicarbonate transporters suggests that the 
kidneys are also involved in acid-base balance. 
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The fluid and solutes remaining in the filtrate at the end of the distal tubule 
are destined for excretion.  The filtrate leaves the distal tubule and enters into a 
collecting duct.  The collecting ducts route the filtrate from numerous nephrons to 
be collected in a calyx, which later empties into the ureter which leaves the 
kidney at the renal hilum.  The ureter transports the filtrate to the bladder, where 
the urine is stored until excreted [30]. 
 
Typical measurements of renal function 
Given the role of the kidney in maintaining blood composition, 
insufficient renal activity can influence multiple organ systems.  Therefore, 
monitoring renal function is of great importance in both clinical and research 
settings.   
Serum markers of renal function include creatinine, blood urea nitrogen 
(BUN), uric acid, total protein, albumin, Ca, and P.  Serum creatinine levels can 
be combined with urinary excretion of creatinine to estimate glomerular filtration 
rate (GFR).  Estimating GFR provides insight into the amount of fluid that is 
filtered by the kidney over a given time (ml/min).  In humans, reduction in GFR 
allows for the severity of renal disease to be determined and is the standard 
method used to assess renal function.  BUN is another common measurement, and 
also provides insight into the filtrating ability of the kidney.  Urea is a waste 
product derived from the metabolism of amino acids, and is removed from the 
circulation through renal filtration.  Therefore, increases in BUN signify renal 
deficiency.  The remaining serum measures (total protein, albumin, Ca, and P) are 
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not specific to renal function.  For example, alterations in serum protein and 
albumin could result from liver abnormalities and not glomerular damage 
resulting in increased excretion of albumin.  Likewise, changes in serum Ca and P 
could result in pathologies associated with bone and or mineral metabolism (such 
as hyperparathyroidism).   
Estimating GFR is by far the most common measure of renal function 
used.  However, less than 10% of the nephrons present in healthy individuals are 
required to maintain blood composition [30].  This large renal capacity makes 
detection of early renal damage difficult using serum measurements.  To address 
this issue, urinary composition can also be measured to determine renal health.  
The urinary markers are similar to those measured in serum and typically include 
albumin, pH, Ca, and P.  Urinary albumin is a powerful measurement, because 
elevated urinary albumin (or total protein content) suggests damage has occurred 
to the filtrating apparatus of the kidney (i.e. glomerulus).  As in the case of serum 
measures, urinary Ca, P, and pH could be the result of dysfunction in other organ 
systems.  However, elevated urinary Ca (hypercalciuria), P (hyperphosphouria), 
and acidity are implicated in the etiology of certain renal diseases.  Dietary 
components can influence the excretion of these compounds, and suggests that 
diet can have a profound influence on renal health.   
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1.3 The influence of dietary components on nephrocalcinosis in rats 
1.3.1 Defining nephrocalcinosis 
Nephrocalcinosis (NC) is a form of kidney disease that refers to the 
accumulation of Ca deposits in kidney tissue.  NC has been documented in several 
animal species (including humans), however there may be differences in the 
etiology.  Due to their sensitivity for NC, the female rat is a common animal 
model.  NC can be induced in female rats with simple changes in dietary mineral, 
protein, and lipid content.  NC has been shown to induce inflammatory processes 
that result in nephron damage and fibrosis, which are involved in the initiation of 
other forms of renal diseases.  Therefore, NC is considered an initiating factor for 
the development of chronic renal disease and renal failure [36, 37]. 
NC typically develops within the tubular lumen, and appears to be 
dependent upon filtrate concentrations.  It is believed that urinary compounds 
typically involved in NC (such as Ca, P, and oxalate) must become insoluble 
before deposition (or nucleation) can occur.  In vitro studies have shown that Ca-
based crystals adhere to anionic glycoproteins on the surface of tubular epithelial 
cells [38].  After a given exposure time, the epithelial cell engulfs the crystal as a 
clearance mechanism.  However, free radical production and cytokine expression 
accompany this process, and leads to the formation of a site for nucleation [39, 
40].   
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1.3.2 Dietary components and NC 
The etiology of NC involves the precipitation of filtrate components 
followed by their attachment to the tubular epithelial cells.  Therefore, factors 
influencing the solubility of urinary components (such as Ca, P, and oxalate) 
mediate the development of NC.  These factors originate from the diet, and 
suggest that dietary alterations influence urinary composition and NC.  This is 
expected since the main function of the kidney is to maintain blood composition 
through the production of urine.     
 
Dietary mineral content 
Variable consumption of Ca, P, and Mg can results in concomitant 
changes in their respective excretion.  Surprisingly, increased consumption of 
dietary Ca is not directly associated with urinary Ca excretion and associated NC 
[41].  However, elevated dietary intake of P is tightly associated with both urinary 
P excretion [42] and severity of NC [43].  Several studies have also addressed the 
interaction of dietary Ca and P in NC, and reported that a dietary Ca:P ratio less 
than 1 is nephrocalcigenic [41].  However, it appears that the absolute amount of 
Ca and P is important and not just the ratio.  Cockell et al., [44] found that the 
severity of NC increased with dietary Ca and P content despite a Ca:P ratio of 1.3.   
 
Dietary protein content 
Dietary protein has also been shown to influence urinary characteristics.  
In fact, Meyer et al., [45] concluded that changing the source of dietary protein 
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had a greater effect on NC than manipulations in dietary mineral content.  This 
finding was later supported by Zhang and Beynen [46], who fed female rats diets 
varying in protein source (casein, soybean, or codmeal) and amount (18, 35, and 
53%).  They noted significant fluctuations in both urinary and renal content, with 
rats fed casein having the highest P excretion, most acidic urine, and highest 
kidney Ca content.  Urinary acidification is a common finding in rats with high 
urinary P content [42, 47].  Urinary acidification could influence NC by 
decreasing proximal tubule P reabsorption and result in increased urinary P 
excretion [48, 49].   
 
Dietary lipid content 
Few publications exist studying the influence of lipids on diet induced NC.  
Schmiedl et al. [50] fed rats a hyperlipidemic-EFA deficient diet high in (1%) 
cholesterol and neutral fat (10%).  As compared to rats fed a standard chow diet 
(5% lipid), rats fed the hyperlipidemic diet had more calcifications (mean of 2840 
vs 392), and higher renal Ca and P content.  Unlike urinary profiles mentioned 
above, the rats with NC did not excrete more P or an acidic urine.  Instead, rats 
fed the hyperlipidemic diet had a more basic urine and higher excretion of oxalate 
leading to development of calcium oxalate (CaOx) deposition.  CaOx is another 
Ca precipitate that can form in basic urine containing elevated oxalate 
concentrations [49].  CaOx is a common form of NC in humans and has potent 
proinflammatory signaling potential [39].  However, CaOx stone formation is 
typically associated with liver or GI dysfunction.  The authors noted that the 
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hyperoxaluria reported was due to changes in liver oxalate synthesis, presumably 
due to the poor quality of the high fat diet.   
Dietary PUFAs may also mediate NC through their proposed anti-
inflammatory actions (Section 1.1.4).  Furthermore, residual ω-3 PUFAs may 
explain why certain protein sources differ in their nephrocalcigenic ability [46].  
ω-3 PUFA supplementation has shown beneficial effects in rodent models of 
hypercalcemic NC.  Burgess et al., [51] and Schlemmer et al. [52] both reported 
decreased renal Ca content in Ca glubonate injected rats supplemented with EPA.  
However, Ca gluconate injections are hypercalcemic and induce NC by sustained 
hypercalciuria (a different mechanism than that normally occurring in rats).  
Additionally, no urinary values or serum values were given to determine if the 
observed NC was specific to the kidney.  Therefore, it is unclear if PUFAs can 
mediate diet induced NC.  Furthermore, different sources of ω-3 PUFAs exist and 
each may differ in ability to modulate the NC induced by feeding different dietary 
protein sources.  Given their role in inflammatory processes and prostaglandin 
production, consuming diets differing in PUFA content may influence renal 
health and the development of NC. 
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2.0 Study Objectives 
Objective 1. To investigate the effect of consuming krill protein concentrate on 
renal and bone health. 
 
Objective 2. To characterize krill oil that has been isolated using different 
processing methods. 
 
Objective 3. To determine how different dietary sources of ω-3 PUFAs 
influence kidney health and function in female rats. 
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3.1 Background 
We have previously shown that krill protein concentrate (KPC) has 
nutritional potential for human consumption [1].  However, these rats also had 
significantly lower kidney weights compared to rats fed casein, the standard 
protein source used in semipurified diets.  Changes in kidney weight have been 
correlated with renal disease, and include potential alterations in mineral 
metabolism [2].  Therefore, the objective of this study was to address this change 
in body weight, and determine if changing the dietary protein source can 
influence measures of mineral metabolism and bone health.  
 
3.2 Introduction 
Diet-induced alterations in kidney health are common in female rats, with 
renal calcification (nephrocalcinosis) being a prime example [3, 4, 5].  The 
transition of nephrocalcinosis to kidney stones (nephrolithiasis) has been 
implicated in nephropathy and subsequent renal failure in rats [5].  Diet-induced 
alterations in the kidney function has been attributed to manipulating various 
components of the diet, including the dietary calcium:phosphorus ratio [6, 7, 8, 9, 
10], and the dietary protein content [11, 12, 13].  Diets rich in phosphorus (P) or 
leading to increased P excretion have been reported as being an underlying cause 
of nephrocalcinosis [14].  However, Meyer et al. [11] reported that changing the 
source of dietary protein fed to female Wistar rats reduced calcium (Ca) 
deposition in the kidneys to a greater extent than manipulating dietary minerals.  
Together the study results suggest that the amount, as well as the source, of 
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dietary protein influences the development of nephrocalcinosis and nephrolithiasis 
[12, 13].  Additionally, different protein sources are associated with different fatty 
acids.  The role of lipids in nephrocalcinosis and nephrolithiasis should be 
considered because fatty acids have been shown to differentially influence 
inflammatory pathways, and inflammation has also been implicated as an 
initiating factor in tissue calcification [15, 16, 17].       
Nephrocalcinosis is commonly associated with increased urinary Ca 
excretion (hypercalcuria), and dietary proteins also influence the excretion of Ca.  
It has been proposed that higher consumption of dietary protein increases 
intestinal Ca absorption and this may increase urinary Ca excretion [18, 19].  The 
consumption of dietary protein has also been correlated with an increase in 
urinary acid excretion [20, 21, 22], which has been shown to reduce renal Ca 
reabsorption and possibly promote hypercalciuria [23].  These potential changes 
in kidney function may influence mineral balance and in turn, bone health.  Calvo 
et al., [24] reported hypercalciuria in male Sprague-Dawley rats fed high protein 
diets; however, there was no effect on bone mineral content.  Female rats display 
a higher sensitivity to alterations in renal handling of Ca [6] and therefore, in the 
present study female rats were used since they may provide a more sensitive 
model for mineral and subsequent bone loss.    
In our study, female Sprague-Dawley rats fed protein derived from a 
pelagic source were compared to rats fed casein, a standard protein source used in 
commercial semi-purified rodent diets.  Fish contain high-quality protein as well 
as other nutrients with potential health benefits.  However, depletion of existing 
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fish stocks and environmental contaminants has raised public concern regarding 
fish consumption.  A potential alternative is to promote consumption of under-
utilized species such as krill.  Based on body size, krill has the largest amount of 
protein (over 65% dry weight) among all organisms worldwide.  Analysis of lipid 
content showed ~27% of total fatty acids in Antarctic krill (Euphausia superba) 
consists of the health benefiting omega-3 polyunsaturated fatty acids (ω-3 
PUFAs) [1, 25].  Krill offers a promising high quality and sustainable source of 
protein for human consumption.  Therefore, the objective of this study was to 
evaluate the effects of consuming KPC in regards to renal and bone health. 
 
3.3 Materials and Methods 
3.3.1 Diets and animal feeding study 
All animal procedures were conducted in accordance with the guidelines 
set forth by the Institute of Laboratory Animal for the Care and Use of Laboratory 
Animals [26], and were approved by the Animal Care and Use Committee at West 
Virginia University. 
Immature (age 28 d) female Sprague-Dawley rats (n=20) were purchased 
from Taconic Farms (Rockville, MD).  Female rats were used due to their higher 
susceptibility to nephrocalcinosis compared to male rats [4].  Upon arrival, rats 
were individually housed in metabolic cages.  All animals were maintained in a 
room at 21
o
C with a 12 h light/dark cycle.  During a 14 d acclimation period, 
animals were given ad libitum access to deionized distilled water (ddH2O) and 
AIN-93G diet (Harklan Teklad, IN).  Following the 14 d acclimation period, rats 
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were randomly assigned (n=10 per group) to be fed ad libitum a low protein diet 
consisting of 10% crude protein supplied as casein or KPC for 4 weeks. 
KPC was isolated from whole frozen Antarctic krill (Euphausia superba) 
purchased from Krill Canada (Langley, BC, Canada) using an isoelectric 
solubilization / precipitation method described previously in Gigliotti et al. [1].  
The recovered KPC was 77.7% crude protein, 8.1% total lipid, and 4.4% total ash 
on a dry basis by proximate analysis.  Freeze-dried KPC was stored at -20
o
C until 
mixed into the diet.  Replacement of the protein as either KPC or casein at a level 
of 10% in AIN-93G diet was corrected for protein and lipids so that the diets were 
isocaloric and isonitrogenous.  Ca and P contents of the diets were also matched 
to provide a 1.2 ratio (Table 1).  Diets were kept stored at 5
o
C.  Food consumption 
and ddH2O intake were measured and replaced with fresh ddH2O and assigned 
diet every 2 d.  
 
3.3.2 Kidney mineral content 
At the end of 4 weeks, rats were euthanized by CO2 inhalation, and both 
kidneys excised.  Kidneys were trimmed, decapsulated, and weighed separately.  
No statistical differences were found between the right and left kidney weights.  
Therefore, the left kidneys were assayed for mineral content and the right kidneys 
used for histological evaluation.  
To determine kidney mineral concentrations, the left kidneys were dried 
overnight at 110˚C in an oven and then ashed at 550oC in a muffle furnace 
(Lindberg 515A2, WI) for 24 h.   To determine specific minerals, ashed samples 
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were dissolved in 70% nitric acid (2 mL) and  neutralized in ddH2O (5 mL).  
Samples were then filtered through Whatman no. 1 paper, diluted to volume (50 
mL), and renal Ca and P content in the kidneys were measured using inductively 
coupled plasma spectrometry (ICP) (model P400, Perkin Elmer, Shelton, CN). 
 
3.3.3 Kidney histology 
The right kidneys (n=4) were dissected and immediately fixed in 10% 
formalin solution overnight and then transferred to 70% ethanol.  Tissues were 
dehydrated through a series of increasing ethanol concentrations (70-100% in 
ddH2O) to xylene, embedded in paraffin, and serially cut in 8µm thick sections 
using a microtome (American Optical Company, NY).  Paraffin embedded 
sections were placed on moist glass slides and dried for mounting.  Mounted 
sections were then deparaffinized in xylene, and rehydrated through a series of 
decreasing ethanol concentrations (100-70%) prior to staining. 
Renal morphology and microtubular calcification was examined by 
standard hematoxylin and eosin (H&E) and periodic acid-Schiff (PAS) staining.  
PAS staining was performed following a commercially available protocol (Sigma-
Aldrich, MO).  Briefly, hydrated slides were incubated in Periodic Acid Solution 
for 5 minutes.  After rinsing in ddH2O, slides were immersed in Schiff’s reagent 
for 15 minutes, washed in water, and then counterstained in Gill Hematoxylin 
solution for 90 seconds and cover slipped.  All slides were analyzed under a 
Nikon TE 2000-S light microscope (Nikon Instruments, NY) at 4X magnification 
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by three trained individuals, and images captured using a PC interfaced with Q-
Capture imaging software (Quantitative Imaging Corporation, BC, Canada). 
 
3.3.4 Urinary assays of renal function and damage 
Rats were individually housed in metabolic cages to collect urine for 
determination of renal function and damage.  Urine samples were collected and 
centrifuged at 1,500 g for 10 min at 4
o
C to remove any debris.  Urine samples 
were aliquoted into fresh tubes and stored at -80
o
C until assayed.  Baseline urine 
consisted of pooled samples collected over 7 d of the first week of treatment.  
Final urine consisted of pooled samples collected over the final 7 d of the 4 week 
feeding study. 
To determined renal function, urinary total protein and creatinine were 
determined using commercially available colorimetric assays (Cayman Chemical, 
MI).  Serum creatinine concentrations were determined enzymatically using a 
commercially available Vet-16 rotor (Hemagen Diagnostics Inc., Columbia, MD).  
Glomerular filtration rate (GFR) was determined based on creatinine clearance 
(CrC) calculated as: CrC = (UC/SC) X V, where UC is urinary creatinine 
concentration, V is the volume of measured urine excreted per minute, and SC is 
serum creatinine concentration.  Renal damage was determined by measuring 
urinary n-acetyl glucosaminidase (NAG) activity, an early indicator of renal 
damage, using a commercially available colorimetric kit (Diazyme, CA).  The 
optical densities of the urinary samples were determined at wavelength 505nm in 
a Beckman DU530 spectrophotometer (Beckman Coulter, CA).  Urinary sodium 
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(Na) was determined by diluting the urine 1:40 (v/v) in ddH2O and measuring the 
mineral concentration using the ICP.  Urinary pH was determined using a 
standard pH meter (Beckman, CA).  
 
3.3.5 Mineral balance 
Mineral balance studies were performed by individually housing rats in 
metabolic cages to determined food intake and to collect feces and urine samples.  
Ca apparent absorption was calculated as (Ca intake - fecal Ca excretion) / Ca 
intake x 100.  Calcium retention was determined by calculating Ca intake - (fecal 
Ca excretion + urinary Ca excretion).  P apparent absorption was calculated as (P 
intake - fecal P excretion) / P intake x 100 and P retention was determined by 
calculating P intake - (fecal P excretion + urinary P excretion). 
Ca and P intake was calculated by multiplying the amount of diet 
consumed and the dietary concentration of Ca (6 mg/g diet) or P (5 mg/g diet) as 
provided by diet manufacturer and confirmed by ICP.  Urine and fecal samples 
consisted of pooled samples collected during the final 7 d of the 4 week feeding 
study.  To determine urinary minerals, samples were diluted 1:40 in ddH2O and 
Ca and P concentration measured by ICP.  To determine fecal minerals, the fecal 
samples were freeze-dried for 48 h.  Feces were ashed overnight in a muffle 
furnace (Lindberg 515A2, WI), dissolved in 70% nitric acid, diluted to 1:50 in 
ddH2O and then Ca and P concentration determined by ICP. 
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3.3.6 Bone measurements 
Both femurs were dissected and defleshed with care being taken not to 
damage the periosteum.  Each femur was wrapped in saline soaked gauze, and 
frozen at -20°C until assayed.  For analysis each bone was brought to room 
temperature.  Bone morphology was determined by measuring length, width, and 
depth using a vernier caliper (Bel-Art Products, NJ). Bones were dried at 110ºC 
for 48 h and dry weights measured using an analytical balance (Mettler Toledo, 
OH).  The dried femurs were ashed at 600
o
C in a muffle furnace (Lindberg 
515A2, WI) for 24 h and total bone mineral content (BMC) determined by the 
weight of the bone ash.  Ashed femur samples were dissolved in 70% nitric acid, 
diluted to 1:50 ddH2O and femoral Ca and P content measured by ICP. 
Femoral strength was determined on a TA.HDi Texture Analyzer (Texture 
Technologies Corp, NY) outfitted with a three-point bending apparatus.  The 
femur was placed on supports (1 mm width at tip) and bent until broken by 
lowering a centrally placed blade (1 mm width) at constant crosshead speed (0.1 
mm/s).  The load-deflection data collected by a PC interfaced with the TA.HDi 
Texture Analyzer was used to determine the bone strength measurement of peak 
force.  Bone morphometry, BMC, Ca, P, and bone strength results of the bone 
pairs were averaged after no differences between right and left femurs were 
determined by paired t-test with significance level set at P<0.05.   
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3.3.7 Statistical analysis 
The animal feeding study was a completely randomized design, with n=10 
rats per diet treatment.  The t-test was used to compare differences between 
treatment groups, and Mann-Whitney Rank Sum test was performed on data not 
normally distributed.  The t-test and the Mann-Whitney Rank test were both 
performed using Sigma Stat 3.1 (Systat Software Inc., San Jose, CA).  Differences 
were considered significant at P<0.05. 
 
3.4 Results 
3.4.1 Kidney mineral content 
Figure 1 shows the relative weights (g/g body weight*100) of the kidneys, 
kidney total mineral (ash), Ca, and P content of rats fed KPC relative to rats fed 
casein.  Kidney weights of rats fed KPC were lower (P<0.001) compared to the 
kidney weights of rats fed casein.  Rats fed KPC had decreased (P<0.001) kidney 
total mineral content compared to rats fed casein.  Measurements of specific 
minerals showed that rats fed KPC also had lower (P=0.002) kidney Ca 
concentrations, and lower (P<0.001) kidney P concentrations compared to rats fed 
casein.  
 
3.4.2 Kidney histology 
H&E and PAS stains were used to detect renal calcium deposits, with 
more than 115 renal tissue sections of n=4 rats / diet used.  All slides containing 
the cortico-medullary junction from rats fed casein displayed extensive 
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microtubular calcification (Figures A and B, top).  Interestingly, only one (Figure 
C) of the four rats fed KPC (Figures C and D) used for histological evaluation 
showed renal calcification in the same region of renal tissue and this was 
comparatively mild compared to casein fed rats. Focal areas of tubular atrophy 
were also observed, however no distinction between the diets could be made.  
There were no indications of fibrosis or other glomerular abnormalities in rats fed 
casein or KPC. 
 
3.4.3 Urinary assays of renal function and damage 
To determine kidney damage and function, various biomarkers were 
determined in urine collected during the final week of the 4 week study.  Table 2 
shows NAG concentrations were lower (P=0.03) in rats fed KPC compared to 
casein.  Although not significant, rats fed KPC tended to have higher CrC 
(P=0.055) and lower total urinary protein (P=0.057) than rats fed casein.  Rats fed 
KPC had a more basic (P=0.004) urinary pH values compared to rats fed casein.  
The urine of rats fed KPC also had higher urinary Na (P<0.001) concentrations 
compared to rats fed casein (Table 2).  
 
3.4.4 Mineral Balance 
Table 3 shows that rats fed KPC had higher a (P=0.02) urinary output after 
the initiation of the diet.  Despite the higher urinary output, there was no 
difference in urinary Ca excretion between rats fed casein and KPC.  There was 
no effect on Ca homeostasis indicated by no significant differences in Ca intake, 
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absorption, retention, or fecal excretion between rats fed KPC or casein at the 
initiation of the diet.  During the final week, rats fed KPC had greater (P<0.001) 
Ca intake than the rats fed casein.  However, there were no differences in 
measures of total Ca intake, absorption, retention, or fecal Ca concentrations 
between rats fed KPC and rats fed casein (Table 3).  
Table 4 shows that consumption of KPC had no effect on P homeostasis at 
the initiation of the diet as indicated by no differences in P intake, absorption, 
retention, urinary, or fecal output between rats fed KPC and rats fed casein.  
During the final week, there was no effect on P homeostasis as indicated by no 
differences in P intake, absorption, retention, urinary or fecal P concentrations 
between rats fed KPC and rats fed casein.  
 
3.4.5 Bone measurements   
Table 5 shows there were no significant differences in femur morphometry 
measurements of weight, length, width or depth between rats fed KPC and rats 
fed casein.  There were no significant differences in femur total BMC of rats fed 
KPC compared to rats fed casein.  Similarly, measurements of the major bone 
minerals indicated no significant difference in either the femoral Ca or P content 
of rats fed KPC compared to rats fed casein.  Measurement of bone strength as 
determined by peak force in the femur showed no significant difference between 
rats fed KPC and rats fed to casein. 
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3.5 Discussion 
Protein quality of KPC is similar to that of casein, a standard protein 
source, used in commercial semi-purified rodent diets [1].  However, female rats 
fed KPC had lower (P<0.001) kidney weights compared to rats fed casein. To 
investigate the effect of KPC compared to casein on kidney health, NAG was 
measured as an early marker of renal injury.  Despite being provided a low (10% 
g/kg diet) protein diet, urinary NAG concentrations were higher (P=0.03) in rats 
fed casein compared to KPC, indicating that protein source is an important factor 
to consider in renal health.  Similarly, NAG excretion was greater in male 
Munich-Wistar rats consuming casein compared to a soy protein based diet.  The 
authors suggested that casein induced renal injury through increased acidification 
of the kidney filtrate [27].  Ritskes-Hoitinga et al., [28] reported that high urinary 
pH values were associated with low degree of nephrocalcinosis indicated by a 
negative correlation (r=0.68, p<0.05) between urinary pH and the severity of 
nephrocalcinosis.  Therefore, in our study higher (P=0.004) urinary pH in rats fed 
KPC compared to rat fed casein may be responsible for preventing early renal 
injury. 
The pathogenesis of nephrolithiasis has been proposed to involve renal 
injury followed by deposition of calcium crystals to the site of injury [29].  In our 
study, kidney mineral content (P<0.01), Ca (P<0.001), and P (P<0.001) 
concentrations were lowered in rats fed KPC compared to casein.  Furthermore, 
histological evaluation of the kidneys showed that rats fed casein had extensive 
renal calcification, whereas mild to absent renal calcification was observed in the 
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kidneys of rats fed KPC.  Similarly, Zhang and Benyen [13] reported that female 
Wistar rats fed cod meal had lower kidney Ca content compared to rats fed casein 
or soybean protein isolate.  Together, the study results suggest that pelagic protein 
sources may provide protection against mineral deposition in the kidneys.   
After an initial renal injury, kidney function often declines [30].  
Determination of urinary total protein excretion provides an estimation of kidney 
filtrating ability with proteinuria considered a risk factor for progressive loss of 
kidney function.  CrC provides an estimation of glomerular filtration rate with 
reduced CrC used as a clinical diagnosis for renal disease [31].  Although not 
significant, rats fed KPC for 4 weeks tended to have lower (P=0.057) urinary total 
protein excretion and higher (P=0.055) CrC compared to rats fed casein.  
Similarly, male Wistar rats fed soy protein had lower urinary total protein and 
higher CrC compared to rat fed casein [32].  These study results indicate that the 
protein source influences renal function.  In the current study, urinary output was 
higher (P=0.02) in rats fed KPC compared to casein-fed rats.  This may have been 
the result of a tendency (P=0.10) for rats fed KPC to consume more ddH2O (970.3 
ml/28d) than rats fed casein (620 ml/28d).  Increased urinary output in rats fed 
KPC may have contributed to the observed decreased kidney mineral content and 
deposition.  Promoting increased urinary output is a common recommendation for 
individuals suffering from kidney mineralization [33].  However, in a study 
comparing different dietary proteins and development of nephrocalcinosis, Zhang 
and Benyen [13] reported that the rats with the lowest kidney mineral content did 
not have the highest urinary outputs.  Therefore, decreased mineralization of the 
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kidneys in rats fed KPC in the current study was likely not the result of an 
increased urinary output alone.   
The tendency for higher glomerular filtration rates and lower urinary total 
protein excretion, accompanied by lower kidney calcification, in KPC compared 
to casein fed rats suggested that consumption of KPC had beneficial effects on 
kidney function.  Furthermore, lower urinary NAG concentration and renal tissue 
Ca deposition suggested that KPC consumption prevented kidney injury.  
However, these beneficial effects may not be due to the protein alone, since KPC 
also contains minerals and lipids that may affect the kidneys. 
KPC is composed of 4.4% minerals by weight [1].  Alterations in dietary 
Ca:P ratio has been reported to play an important role in the development of  
nephrocalcinosis [7].  Increasing the Ca:P ratio to greater than 1.0 has been 
reported to prevent nephrocalcinosis [8].  In our study the KPC and casein diets 
were formulated to have matching Ca and P concentrations which resulted in a 
Ca:P ratio of 1.2.  Therefore, it appears that decreased kidney mineralization in 
rats fed KPC was not due to differences in dietary Ca and P content. 
Common urinary abnormalities associated with nephrocalcinosis and 
nephrolithiasis are hypercalciuria and/or hyperphosphouria.  In our study there 
were no differences in urinary Ca and P concentrations between rats fed KPC and 
casein.  Unexpectedly, rats fed KPC had a 4 fold increase in urinary Na compared 
to rats fed casein. Subsequent analysis of diets showed that KPC had twice the Na 
content of the casein diet.  Increased Na was likely due to the processing method 
used to obtain KPC.  As a result rats fed KPC consumed twice the amount of Na 
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compared to rats fed casein.  Higher Na consumption in rats fed KPC may explain 
their tendency (P=0.10) to consume more ddH2O, and in turn, their increased 
urinary output.  High urinary Na has been suggested to interfere with tubular Ca 
reabsorption leading to hypercalciuria, a risk factor for nephrocalcinosis and 
nephrolithiasis [34, 35].  In the current study, the increased urinary Na in rats fed 
KPC did not appear to affect urinary Ca excretion compared to rats fed casein.  
Furthermore, Mattson et al., [36] concluded that dietary composition significantly 
influenced the development of renal disease in salt sensitive rodent models 
independent of the NaCl content.  Taken together these data suggest that the 
mineral content of the diet is not the sole determinant of urinary mineral 
excretion, a risk factor for developing nephrocalcinosis.  This finding is supported 
by Meyer et al., [11] who reported that changing the source of protein in semi-
synthetic diets reduced mineral deposits, and this exceeded the effects of changing 
the mineral composition of the diet.   
KPC also contains a lipid component that may benefit renal health.  
Gigliotti et al. [1] reported that KPC consists of 8.1% lipid by weight.  The lipids 
in KPC are rich (~27%) in the ω-3 PUFAs, eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA).  EPA and DHA have anti-inflammatory properties 
that potentially contributed to renal health.  Rats fed cod meal, a potential source 
of EPA and DHA, were reported to have reduced kidney Ca concentrations 
compared to rats fed casein or soy isolate [13].  Furthermore, Schlemmer et al. 
[37] reported that rats supplemented with ω-3 PUFAs had decreased calcification 
of the renal tubules.  Consuming KPC as a source of protein provides a high 
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quality protein with the added benefit of ω-3 PUFAs, whereas other high quality 
protein foods tend to be high in saturated fatty acids. 
In addition to renal injury, changes in renal function may negatively affect 
Ca and P balance, which can lead to compromised bone health [38].  Protein 
source appears to affect Ca and P absorption and retention.  Van Dael et al. [39] 
reported that replacing casein with whey protein diets resulted in higher 
absorption of Ca and higher absorption and retention of P.  In our study, there 
were no differences between Ca and P absorption and retention in rats fed KPC 
compared to casein.  Furthermore, bone measurements showed no differences in 
femoral total bone mineral content, Ca, P or bone strength between rats fed KPC 
and casein.  Similarly, the lower urinary pH observed in rats fed casein had no 
effect on bone mass or strength measurements.  It is likely that extracellular pH 
was not lowered sufficiently to activate bone resorption in rats fed casein, a 
proposed mechanism for protein induced bone loss [40].  Studies addressing bone 
loss due to lower pH commonly use high protein diets of up to 50% protein.   It 
was unlikely that our diet consisting of 10% protein would promote the metabolic 
acid load required to affect bone health.  Recent evidence suggests that dietary 
protein may be as important as dietary Ca in preventing bone loss [41, 42].  Bone 
tissue is formed by the mineralization of the collagen, a protein-derived 
connective tissue.  Thus, dietary protein may contribute to bone density and 
strength by promoting complete bone matrix formation. 
In conclusion, early renal injury and Ca deposits were influenced by the 
protein source fed to young female Sprague-Dawley rats, even with a low protein 
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diet (10% g/kg diet).  Therefore, it is important not only to consider the amount, 
but also the source of dietary protein.  Compared to rats fed casein, the 
consumption of KPC prevented early renal injury.  This was indicated by the 
lower urinary NAG, reduced kidney mineralization, and a tendency for higher 
glomerular filtration rates and lower proteinuria.  Other nutrients associated with 
KPC, particularly the ω-3 PUFA rich lipids, may also have contributed to reduced 
kidney injury and Ca deposition.  In addition to the beneficial effect on the 
kidney, KPC consumption had no effect on bone mass or strength.  Based on the 
study results, KPC is a novel and sustainable protein source which appears to 
attenuate the development of diet-induced alterations in renal health and 
associated bone loss in rats.  
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Table 1.  Diet Composition  
 
 Ingredients (g/kg diet) 10% Casein 10% KPC
b 
Casein 115 0 
DL-Methionine 1.5 0 
KPC 0 128 
Sucrose 531.8 609.8 
Corn Starch 200 229.4 
Corn Oil 53.5 49.9 
Cellulose 52 59.6 
Vitamin Mix
a 
10 11.5 
Ethoxyquin 0.01 0.01 
Mineral Mix
a 
13.4 15.3 
Calcium Phosphate 20.2 20.9 
Calcium Carbonate 2.6 3.6 
Gross Energy (kcal/g) 4.3 4.3 
KPC, krill protein concentrate 
a
 Based on the AIN-93G vitamin and mineral mixes [7]. 
b
 Diet formulated for 872 g of diet + 128 g addition of KPC 
63 
 
Table 2.  Urinary assays for kidney damage and function in female Sprague-Dawley rats 
fed different dietary sources of protein. 
Biomarkers
a 
Casein
b 
KPC
b 
P value 
Urinary NAG (IU/L) 22.9 ± 6.9 3.9 ± 1.0 0.005 
CrC (ml/min) 1.7 ± 0.7 5.5 ± 2.1 0.055 
Total Urinary Protein (µg/ml) 0.6 ± 0.02 0.5 ± 0.03 0.057 
Urinary pH  7.5 ± 0.5 9.0 ± 0.02 0.004 
Urinary Na (mg/7d) 81.3 ± 10.4 246.2 ± 40.1 <0.001 
CrC - creatinine clearance; NAG - n-acetyl glucosaminidase; Na – sodium  
a  
Rats were individually housing in metabolic cages. Urine samples consisted of pooled 
samples collected during the final 7 d of the 4 week feeding study.  
 
b 
Values are expressed as the mean ± SEM of n=10 rats/group.  The t-test was used to 
compare differences between treatment groups,  Differences were considered significant 
at P<0.05. 
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Table 3.  Calcium balance of female Sprague-Dawley rats fed different dietary sources of 
protein 
Measurements
a 
Casein KPC  P value 
Total Ca Intake 3.16 ± 0.08 3.23 ± 0.08 0.5 
First Week 
   Urinary Output (ml/d) 6.05 ± 3.5 13.9 ± 3.4 0.02 
Fecal Output (mg/d) 1.9 ± 0.1 2.03 ± 0.1 0.7 
Ca Intake (mg/d) 82.0 ± 2.7 82.6 ± 3.7 0.9 
Ca Apparent Absorption (%) 40.2 ± 4.4 46.6 ± 3.7 0.6 
Fecal Ca Excretion (mg/d) 43.0 ± 5.6 44.1 ± 3.7 0.7 
Urinary Ca Excretion (mg/d) 0.67 ± 0.2 1.01 ± 0.3 0.4 
Ca Retention (mg/d) 22.3 ± 2.8 26.3 ± 2.4 0.6 
Final Week 
   Urinary Output (ml/d) 6.7 ± 2.9 13.6 ± 3.6   0.03 
Fecal Output (mg/d) 2.2 ± 0.134 2.2 ± 0.113 0.9 
Ca Intake (mg/d) 111.0 ± 4.4 133.0 ± 2.7 <0.001 
Ca Apparent Absorption (%) 23.8 ± 5.1 31.1 ± 6.4 0.7 
Fecal Ca Excretion (mg/d) 83.7 ± 4.3 79.9 ± 11.4 0.7 
Urinary Ca Excretion (mg/d) 3.3 ± 0.7 3.6 ± 1.7 0.3 
Ca Retention (mg/d) 19.1 ± 4.1 31.4 ± 6.6 0.2 
Serum Ca (mg/dl) 11.5 ± 0.4 11.4 ± 0.8 0.6 
a
Values are expressed as the mean ± SEM of n=10 rats/group.  The t-test was used to 
compare differences between treatment groups,  Differences were considered significant 
at P<0.05. 
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Table 4.  Phosphorus balance of female Sprague-Dawley rats fed different dietary sources 
of protein 
Measurements
a 
Casein KPC  P value 
Total P Intake (mg/28d) 2.44 ± 0.06 2.50 ± 0.06 0.5 
First Week 
   P Intake (mg/d) 89.7 ± 3.0 90.9 ± 4.1 0.8 
P Apparent Absorption (%) 71.3 ± 2.4 74.8 ± 1.7 0.5 
Fecal P Excretion (mg/d) 25.1 ± 1.9 23.1 ± 2.0 0.8 
Urinary P Excretion (mg/d) 18.2 ± 3.7 13.7 ± 1.1 0.3 
P Retention (mg/d) 30.3 ± 3.4 37.9 ± 2.5 0.3 
Final Week 
   P Intake (mg/d) 87.6 ± 3.4 91.3 ± 1.9 0.4 
P Apparent Absorption (%) 47.4 ± 3.9 51.2 ± 4.6 0.8 
Fecal P Excretion (mg/d) 45.1 ± 2.3 42.2 ± 3.3 0.4 
Urinary P Excretion (mg/d) 15.6 ± 1.4 13.5 ± 0.8 0.2 
P Retention (mg/d) 19.9 ± 3.6 25.5 ± 3.2 0.4 
Serum P (mg/dl) 11.3 ± 0.4 10.7 ± 0.5 0.4 
a
Values are expressed as the mean ± SEM of n=10 rats/group.  The t-test was used to 
compare differences between treatment groups,  Differences were considered significant 
at P<0.05. 
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 Table 5.  Bone measures in female Sprague-Dawley rats fed different dietary sources of 
protein 
Measurements
a 
Casein KPC  P value 
Femoral Weight (g) 0.53 ± 0.02 0.55 ± 0.02 0.4 
Femoral Length (mm) 27.2 ± 0.22 27.3 ± 0.33 0.9 
Femoral Width (mm) 3.8 ± 0.09 3.7 ± 0.14 0.5 
Femoral Depth (mm) 3.00 ± 0.03 2.98 ± 0.04 0.7 
Femoral BMC (g) 0.54 ± 0.03 0.52 ± 0.01 0.2 
Femoral Ca (mg/g) 41.4 ± 4.6 39.0 ± 1.7 0.7 
Femoral P (mg/g) 55.0 ± 8.8 67.5 ± 7.9 0.5 
Femoral Strength (N) 159.0 ± 6.5 174.6 ± 9.1 0.2 
a
Values are expressed as the mean ± SEM of n=10 rats/group.  The t-test was used to 
compare differences between treatment groups.  Differences were considered significant 
at P<0.05.
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Figure 1.  Weights and total mineral, Ca, and P content of kidneys from rats fed 10% 
protein diets consisting of either casein or KPC for 4 weeks.  Data presented as percent 
relative to casein.  Symbols indicate significant difference of P=0.002 (*) or P<0.001 
(**) by t-test.   
KPC, krill protein concentrate. 
 
Figure 2.  Hematoxylin and eosin (H&E) stained renal tissue from rats fed 10% protein 
diets consisting of either casein (A & B) or KPC (C & D) for 4 weeks.  Arrows highlight 
mineral deposition observed at 4X magnification. 
KPC, krill protein concentrate.
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4.1 Background 
Results from Chapter 1 (Section 3) indicated that nephrocalcinosis and 
associated kidney injury was lower in rats fed KPC as compared to casein.  
Similar results have been reported elsewhere.  Replacing casein with soybean, 
flaxseed, or codmeal also resulted in decreased kidney Ca content, suggesting that 
casein is nephrocalcigenic [1].  However, why different proteins have varying 
influence on kidney health remains unclear.   
It is understood that changing the source of dietary protein also changes 
the dietary lipid content.  In some animal studies, the protein sources used have 
commonly contained residual lipid content [1, 2].  This could explain how 
different protein sources differentially influence kidney health, since soybean, 
flaxseed, codmeal, and KPC are known sources of ω-3 PUFAs.  Rodent models of 
kidney disease have benefitted from ω-3 PUFAs supplementation [3, 4].  
Therefore, the residual ω-3 PUFA content of KPC may be responsible for the 
decreased nephrocalcinosis. 
Conumsption of ω-3 PUFAs has been associated with multiple health 
benefits, and therefore has become a well-recognized nutritional supplement.  
Krill oil is an available ω-3 PUFA supplement and it is advertised as being a 
superior ω-3 supplement due to its high phospholipid content [5].  Health claims 
state that there are nutritional benefits of consuming phospholipids as opposed to 
triglycerides; however little compelling evidence exists supporting these claims. 
The unique composition of krill oil also has manufacturing implications.  
This unique lipid composition can pose difficulties during the processing of krill 
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oil, resulting in inefficient usage of the nutritional properties of krill.  Given the 
vital role of krill in its ecosystem, and its valuable nutritional potential, efficient 
usage of this resource is vital.  Therefore, the objective of the next study is to 
determine the composition of krill oil isolated using different processing methods.    
 
4.2 Introduction  
Antarctic krill (Euphausia superba) are small, shrimp-like planktonic 
crustaceans found predominately in the Southern ocean.  Despite their small size, 
the Antarctic krill is estimated to be one of the most numerous multicellular 
organisms on the planet [6].  A sustainable harvest of krill has been estimated at 
70-200 million tons (MT) [7]), whereas the total annual capture of all fisheries has 
been approximately 130 MT since 2000 [8].  Although it is difficult to accurately 
determine the fluctuating krill biomass [9], the harvest of krill alone could be 
comparable to the biomass of all other aquatic species currently harvested by 
humans.  Nicol and Foster [10] estimated a potential annual krill capture to be 0.1 
MT, making krill an underutilized species given proper harvest managment [11, 
12, 13]. 
Despite this large biomass, the use of krill as a human food source has 
been limited [7].  The interest in using krill as a food source stems from its 
nutrient composition, where krill was reported to contain 77.9-83.1% moisture, 
11.9-15.4% protein, 0.4-3.6% lipids, and ~2% chitin and glucides [14].  Krill 
protein has been shown to be high quality, making krill a large potential source of 
valuable dietary protein [15].  In addition, krill oil is currently marketed as a 
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valuable dietary supplement, due to its unique lipid composition.  Traditionally, 
triglycerides (TRIGs) are the largest component of dietary oils and can represent 
over 60% of the lipid by TLC and densitometry analysis (unpublished data).  
However, krill oil has been cited as having around 40% phospholipid by weight 
[5].  In addition, Kolakowska et al. [16] reported that krill oil is rich in the omega-
3 polyunsaturated fatty acids (ω-3 PUFAs) eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA).  Intakes of EPA and DHA are associated with 
decreased risk of cardiovascular disease [17].  Furthermore, krill oil is also rich in 
the carotenoid astaxanthin,  which is a potent antioxidant and provides additional 
neutraceutical value [18].  Together, these multiple bioactive components have 
resulted in various clinical benefits associated with krill oil consumption [19, 20, 
21].    
Given their role in Antarctic ecosystems, it is crucial to develop ways to 
efficiently utilize harvested krill.  Currently, krill oil is extracted by a two-step 
solvent extraction using acetone and then ethanol in the first and second step, 
respectively [21, 22]  However this extraction requires two separate processing 
steps and is preferably conducted overnight.  This long incubation time could 
potentially result in the degradation of lipids and proteins due to the rapid 
autolysis that occurs in krill post-mortem [23].  Additionally, there is no mention 
about water removal from krill prior to oil extraction.  Research has shown an 
improved extraction efficiency is obtained with krill dehydration prior to oil 
extraction [24].  Other popular processing methods use superctitical-CO2 
entrained with up to 20% ethanol, and uses heat to inactivate endogenous krill 
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lipases [25].  The heating process (>50C) is efficient at inactivating the 
endogenous lipases; however heating may also denature heat-labile krill proteins 
[26].  Denaturation of these proteins likely result in a low recovery, and the 
recovered proteins would unlikely be functional (i.e., gel-forming ability, water-
holding-capacity, emulsification, etc).  This process also does not require water 
removal prior to processing, despite lyophilized krill having a threefold increase 
in lipid extraction efficiency using the supercritical-CO2 method.  
Therefore, we hypothesize that one-step extraction with acetone:ethanol 
mixture for 2 h from freeze-dried whole krill will result in high extraction 
efficiency.  The study objectives were to determine: (1) oil extraction efficiency 
from whole krill using different solvent systems, (2) lipid classes of extracted oils, 
(3) FA profile of the lipid classes, (4) antioxidant capacity and cholesterol content 
of extracted oils, and (5) composition of the residual spent krill following oil 
extraction.  The residual protein in the spent krill could be recovered with 
established techniques, such as isoelectric solubilization/precipitation.  If protein 
functionalities are retained, this protein could be used in human food products and 
would contribute to the efficient utilization of this tremendous resource [27, 28, 
29]. 
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4.3 Materials and methods 
4.3.1  Sample preparation and oil extraction   
Whole frozen Antarctic krill (Euphausia superba) was obtained from Krill 
Canada (Langley, BC, Canada).  The krill blocks were transported overnight to 
the West Virginia University food science laboratory in heavily insulated 
industrial strength boxes filled with dry ice.  Upon arrival the boxes were 
immediately stored at -80C until use.  Whole frozen krill was freeze-dried 
without thawing (VirTis Genesis 35SQ Super XL freeze-dryer, Virtis, Gardiner, 
NY, USA), vacuum-packed and stored at -80C until processed.  A flow diagram 
of oil extraction from krill is shown in Figure 1. 
In the one-step extraction oil was extracted from freeze-dried krill using 
1:1 acetone:ethanol (v:v) solvent mixture (ACS grade acetone, Fisher Scientific, 
Fairlawn, NJ, USA; ACS grade 95% ethanol, Pharmco, Brookfield, CT, USA).  
The following krill:solvent ratios were tested 1:6, 1:9, 1:12, and 1:30 (w:v).  The 
weight of the initial freeze-dried krill was recorded in order to determine 
extraction efficiency (see below).  The 1:30 ratio was used in the present study to 
mimic the 1:6 ratio of whole fresh krill as described by [21] and [22].  Fresh 
whole krill is currently used in commercial oil extraction [21, 22, 25].  However, 
in the present study freeze-dried krill was used [24]  Therefore, 1:30 ratio (freeze-
dried krill) used in the present study approximately corresponded to 1:6 ratio 
(fresh whole krill) during commercial krill oil extraction with respect to lipid 
content in relation to the solvent volume.  Freeze-dried krill was dispersed in the 
solvent mixture (acetone:ethanol) by homogenization for 30 s using a laboratory 
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blender (model 51BL31, Waring Commercial, Torrington, CT, USA).  Oil 
extraction was conducted for 2 h at 4C using a continuous shaker (model Excella 
E25R, New Brunswick Scientific, Edison, NJ, USA) followed by centrifugation at 
10,000 x g for 20 min and 4C (model Sorvall RC-5B Refrigerated Superspeed, 
Kendro Laboratory Products, Newtown, CT, USA).  The supernatant (i.e., 
extracted krill oil) was decanted and dried under air at atmospheric pressure.  The 
sediment (residual spent krill including protein, shell, etc.) was also dried under 
air at atmospheric pressure and analyzed for crude protein (Kjeldahl), total fat 
(Soxhlet), and ash content (see below).   
In the two-step extraction oil was extracted from freeze-dried krill using 
two separate extractions.  The weight of the initial freeze-dried krill was recorded 
in order to determine extraction efficiency (see below).  The freeze-dried krill was 
first mixed with acetone at a 1:6 ratio (krill:acetone, w:v), centrifuged, and then 
the sediment was mixed with ethanol at a 1:6 ratio (krill:ethanol, w:v), followed 
by final centrifugation.  Therefore, two separate extracts were obtained.  Acetone 
extract was obtained in step 1 and ethanol extract in step 2.  In step 1 freeze-dried 
krill was dispersed in acetone by homogenization for 30 s using the laboratory 
blender.  Oil extraction in step 1 was conducted for 2 h at 4C using the 
continuous shaker followed by centrifugation at 10,000 x g for 20 min and 4C.  
The supernatant (i.e., acetone extract) was decanted and dried under air at 
atmospheric pressure; while the sediment was subjected to step 2 of the 
extraction.  Step 2 was conducted in the same manner as step 1 except ethanol 
was used instead of acetone.  Therefore, total extraction time (i.e., step 1 and 2) 
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was 4 h.  Following step 2, final centrifugation at 10,000 x g for 20 min and 4C 
was applied.  The supernatant (i.e., ethanol extract) was decanted and dried under 
air at atmospheric pressure.  The sediment (residual spent krill including protein, 
shell, etc.) was analyzed for crude protein (Kjeldahl), total fat (Soxhlet), and ash 
content (see below). 
Dry krill oils (i.e., krill oil from one-step extraction, acetone extract from 
two-step extraction, and ethanol extract from two-step extraction) were clarified 
in 2:1 chloroform:methanol (v:v) mixture (ACS grade chloroform, Fisher 
Scientific, Fairlawn, NJ, USA; HPLC grade methanol, Fisher Scientific, Fairlawn, 
NJ, USA) with 20 ml of 10% NaCl in water added to a separation funnel [30].  
This clarification removed any residual water in the krill oil samples.  Sufficient 
volume of the chloroform:methanol mixture was added until there was no visible 
separate layers.  Following clarification, the krill oil samples were re-dried under 
air at atmospheric pressure.  Dry clarified krill oils were weighed and compared to 
the initial weight of the freeze-dried krill subjected to extraction in order to 
determine extraction efficiency (see below).  The lipid classes of the oils were 
determined by thin layer chromatography (TLC).  Fatty acid profile (FAP) of the 
lipid classes was determined with gas chromatography (GC).  In addition, 
cholesterol content and antioxidant capacity of the oils were determined.  These 
analyses are described in the subsequent sections. 
For comparison, oil was also extracted from freeze-dried krill using the 
Folch method and Soxhlet extraction [31].  In Folch method, 3g of freeze-dried 
krill were dispersed in 60 ml of the 2:1 chloroform:methanol mixture by 
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homogenization for 30 s using the laboratory blender, followed by filtration 
through Whatmann nr 40 paper (Whatman International, Maidstone, UK) in the 
separation funnel.  An aliquot of 20 ml of 10% NaCl in water was added to the 
separation funnel and the mixture was manually shaken and allowed to stand until 
the phases had completely separated.  The bottom organic solvent phase was 
removed and dried under air at atmospheric pressure.  The drying resulted in 
solvent evaporation yielding krill oil.  The weight of krill oil was recorded in 
order to determine extraction efficiency.  In Soxhlet extraction, 3 g of freeze-dried 
krill were dispersed in petroleum ether (ACS grade petroleum ether, VWR 
International, Bridgeport, NJ, USA) [31].  The extraction was carried out in a 
standard Soxhlet apparatus for 18 h [32, 33], followed by drying under air at 
atmospheric pressure.  The drying resulted in evaporation of petroleum ether 
yielding krill oil.  The weight of krill oil was recorded in order to determine 
extraction efficiency.  The same set of analyses was performed for krill oil 
extracted with Folch method and Soxhlet extraction as described above for oils 
extracted with one- and two-step extractions (i.e., extraction efficiency, TLC, GC, 
cholesterol content, and antioxidant capacity). 
In preliminary experiments, the above solvent systems were applied to 
extract oil from fresh krill and freeze-dried krill.  The extraction efficiency was 
significantly lower (P0.05) for all solvent systems using fresh krill when 
compared to freeze-dried krill.  These preliminary experiments confirmed earlier 
reports [24].  Therefore, the data from preliminary experiments is not shown and 
oil extracted from fresh krill was not used for analyses described in the 
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subsequent sections (i.e., TLC, GC, cholesterol content, and antioxidant capacity).  
This is also why only freeze-dried krill was used in the present study.  All oil 
extractions were performed in triplicate (n = 3) using the same batch of fresh and 
freeze-dried krill. 
 
4.3.2. Extraction efficiency 
The weight of the initial freeze-dried krill prior to the extraction with 
different solvent systems was recorded.  Following extraction, the weight of 
extracted oils was also recorded.  The weight of acetone extract and ethanol 
extract were combined in order to determine an overall extraction efficiency of 
the two-step extraction.  The extraction efficiency was determined according to 
the following equation: 
 
Extraction Efficiency = 100
(g) extraction  tosubjected krill dried-freeze ofweight 
(g) oil krill extracted ofweight 
  
 
Extraction efficiency is expressed as grams of extracted oil per 100 grams 
of freeze-dried krill subjected to the extraction. 
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4.3.3. Determination of lipid classes with thin layer chromatography (TLC) 
and densitometry analysis  
Thin layer chromatography (TLC) was applied to resolve lipid classes of 
the oils extracted with all extraction methods tested in the present study (i.e., one-
step, two-step, Folch, and Soxhlet).  For krill oil extracted with the two-step 
extraction, TLC and subsequent densitometry analysis were applied to acetone 
and ethanol extracts (Figure 4).  An aliquot of 10 mg of the oil extracted from 
krill was dissolved in 1:1 chloroform:methanol (v:v) and loaded onto TLC plates 
(Whatman K6F silica plates with 60 A pore sizes, P.J. Cobert Associates, St. 
Louis, MO).  The TLC plates were developed using a 80:20:1.5 
hexane:ether:acetic acid solution (v:v:v) as a mobile phase.  Once developed, 
plates were air-dried for 5 min.   
Plate images were captured using a digital camera interfaced with a PC 
and spot densitometer using transluminating white light (Alpha Innotech Corp., 
San Leandro, CA).  The images were analyzed using the Fluorchem software (ver. 
1.0).  Phospholipid (PL) and TRIG classes were identified using RF values 
obtained from triolein (Sigma-Aldrich, St. Louis, MO) and soybean lecithin 
(Fisher Scientific, Fairlawn, NJ) standards.  Once identified, the bands 
corresponding to PL, TRIG, and polar non-PL class were extracted (i.e., scraped) 
from the TLC plates and suspended in 1:1 chloroform:methanol (v:v) for 
determination of fatty acid profile (FAP) by gas chromatography (GC).  
Although at least three replicate TLC plates were run per each extraction 
method (one-step, two-step, Folch, and Soxhlet), only a representative image 
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(three replicates) of the krill oil extracted with one-step extraction using 1:12 
krill:solvent ratio (w:v) is shown in Figure 3.  However, Figure 4 shows 
densitometry data for all extraction methods (one-step, two-step, Folch, and 
Soxhlet).  The densitometry data was analyzed statistically; and therefore, the 
densitometry data in Figure 4 is quantitative; while the sample TLC image shown 
in Figure 3 is qualitative.  The densitometry data are reported as mean values ( 
standard deviation) of at least three replicates and the mean values are expressed 
as percent of lipid class in total krill oil.       
 
4.3.4.  Determination of fatty acid profile (FAP) of phospholipids (PL) and 
triglycerides (TRIG) with gas chromatography (GC) 
TLC was applied to resolve lipid classes of the oils extracted with all 
extraction methods tested in the present study (i.e., one-step, two-step, Folch, and 
Soxhlet) (Figure 3 and 4).  However, only phospholipids (PL) and triglycerides 
(TRIG) had detectable levels of FA (data not shown).  Since PL was the major 
lipid class containing FA (PL – 20-33% vs. TRIG – 1-3%; Figure 4), preliminary 
experiments were conducted in order to determine if extraction methods (i.e., one-
step, two-step, Folch, and Soxhlet) had an effect (P0.05) on composition of FA 
(i.e., FAP).  FAP for PL extracted with all extraction methods was determined 
(data not shown).  However, the contents of major FA were not (P0.05) different 
regardless of the extraction method.  Therefore, extraction methods tested in the 
present study did not (P0.05) affect FAP of the extracted oils.  In addition, 
Figure 2 indicates that one-step extraction resulted in the highest (P0.05) 
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extraction efficiency for 1:12 and 1:30 krill:solvent ratio (w:v); while the 
extraction efficiency at 1:12 and 1:30 was similar (P0.05).  Therefore, only FAP 
for PL and TRIG extracted with one-step extraction using 1:12 krill:solvent ratio 
(w:v) is reported (Figure 5).   
Lipid classes (i.e., PL and TRIG) were extracted (i.e., scraped) from the 
TLC plates.  The PL and TRIG were separately extracted from the TLC scrapings 
according to [30] and FAP was determined as described elsewhere [33, 34, 35, 
36].  FA were transmethylated by the addition of 4 ml of 4% (w:v) methanolic 
H2SO4 and heated in a water bath set at 90C for 60 min.  The mixture was 
saponified by transferring through a Na2SO4-filled glass Pasteur pipette and 
subsequently dried under N2 in a water bath set at 60C for 60 min.  The FA 
methyl esters (FAME) were re-suspended in filtered iso-octane (HPLC grade iso-
octane, Fisher Scientific, Fairlawn, NJ, USA).  The FAME were analyzed by a 
GC (model CP-3800, Varian Analytical Instruments, Walnut Creek, CA, USA) 
using flame ionization detector fitted with a WCOT-fused silica capillary column 
(50 m length, 0.25 mm inside diameter; Varian Analytical Instruments, Walnut 
Creek, CA, USA).  Injection and detection temperatures were maintained at 
220C and column temperature was 190C.  The stationary phase was CP-Silica 
88 (Varian Analytical Instruments, Walnut Creek, CA, USA).  Nitrogen was the 
carrier gas and a split ratio of 10 to 1 was used.  The FA were identified by 
comparing their retention times with those of known standards  Peak area and the 
amount of each FA were computed by an integrator using the Star GC 
workstation version 6 software (Varian Analytical Instruments, Walnut Creek, 
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CA, USA).  The data are reported as mean values ( standard deviation) of at 
least three replicates and the mean values are expressed as percent of a fatty acid 
in total fatty acids. 
 
4.3.5. Cholesterol content in extracted krill oils 
Due to the prevalence of polar, non-PL class (Figure 3), the TLC and 
densitometry analysis did not allow specific determination of cholesterol content.  
Cholesterol was probably contained within the polar, non-PL class.  However, 
krill is a shellfish; and therefore, determination of cholesterol content in the oil 
extracted from krill in this study was of interest.  However, two-thirds of the 
sterols in shellfish such as krill are non-cholesterol sterols interfering with 
cholesterol absorption [37, 38].   Therefore, cholesterol content of oil extracted 
from krill with all extraction methods (i.e., one-step, two-step, Folch, and 
Soxhlet) was determined using a colorimetric assay (catalog number 428901, 
EMD Chemicals Inc., an affiliate of Merck, Darmstadt, Germany).  For krill oil 
extracted with the two-step extraction, cholesterol content was separately 
determined for acetone and ethanol extracts (Figure 6).  This cholesterol assay 
relies on the oxidation of cholesterol by added cholesterol oxidase and yielding 
H2O2.  The resulting H2O2 interacts with a cholesterol probe to produce resorufin 
that is detected spectrophotometrically.  The results are compared to a standard 
curve constructed with cholesterol standards.  
Krill oil samples were prepared in a cholesterol reaction buffer.  In a 96 
well microplate, 50 L of the buffered krill oil samples were mixed with 50 L of 
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reaction mix (containing cholesterol oxidase and cholesterol probe).  Samples 
were covered and incubated at 37C for 1h.  Absorbance was read at 570 nm 
using a Spectramax Plus microplate reader (Molecular Devices, Sunnyvale, CA).  
In order to determine cholesterol content in krill oil, standard curve was 
constructed using cholesterol standards mixed with 50 L of the reaction mix.  
The cholesterol content is reported as mean values ( standard deviation) of at 
least three replicates and the mean values are expressed as grams of cholesterol 
per 100 grams of krill oil. 
 
4.3.6. Antioxidant capacity (trolox equivalents – TE) of extracted krill oils  
The oil extracted from krill in a present study had a deep maroon red 
color.  It has been reported that krill oil is rich in antioxidants, in particular 
astaxanthin [7, 16, 39, 40].  These antioxidants were likely included in the polar 
non-PL class.  Therefore, total antioxidant capacity for the oil extracted from krill 
with all extraction methods (i.e., one-step, two-step, Folch, and Soxhlet) was 
determined and compared to trolox equivalents (TE) according to a colorimetric 
antioxidant assay (catalog number 709001, Cayman Chemical Company, Ann 
Arbor, MI).  For krill oil extracted with the two-step extraction, total antioxidant 
capacity was separately determined for acetone and ethanol extracts (Figure 7).  
This antioxidant assay relies on the ability of endogenous antioxidants in krill oil 
to inhibit the metmyoglobin-mediated oxidation of ABTS (2,2’-Azino-di-[3-
ethylbenzthiazoline sulphonate]) to ABTS
+
.  ABTS and metmyoglobin were 
added to krill oil samples as reagents and the amount of ABTS
+ 
was determined 
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spectrophotometrically.  The capacity of the endogenous antioxidants in krill oil 
to prevent ABTS oxidation was compared with that of a water-soluble tocopherol 
analogue, trolox (6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid).   
In a 96 well microplate, 10 L of krill oil samples were mixed with 10 L 
of metmyoglobin and 150 L of ABTS.  To initiate the reaction, 40 L of H2O2 
was added to each well.  Samples were covered and incubated at room 
temperature on a shaker for 5 min.  Absorbance was read at 750 nm using a 
Spectramax Plus microplate reader (Molecular Devices, Sunnyvale, CA).  In 
order to determine TE for krill oil, standard curve was constructed using trolox 
standards mixed with 10 L of metmyoglobin and 150 L of ABTS.  The 
antioxidant capacity is reported as mean values ( standard deviation) of at least 
three replicates and the mean values are expressed as micromols of TE per 
milliliter of krill oil. 
 
4.3.7.  Crude protein (Kjeldahl), total fat (Soxhlet), and ash content of the 
residual spent krill following oil extraction 
The crude protein, ash content, and total fat were determined in the 
residual spent krill following oil extraction with one- and two-step extraction only 
(i.e., sediment in Figure 1).  Crude protein was determined by Kjeldahl assay 
(AOAC, 1995).  Ash content was performed by incinerating samples in a muffle 
furnace at 550C for 24 h [31].  Residual fat content was determined according to 
the Soxhlet extraction method [31].  To determine proximate composition (i.e., 
crude protein, total fat, and ash content) on dry basis, the residual spent krill was 
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analyzed for moisture content.  A sample (2 g) was placed on an aluminum dish 
(Fisher Scientific, Fairlawn, NJ, USA), spread evenly across the dish and oven-
dried (105C for 24 h) [31].  The proximate data are reported as mean values ( 
standard deviation) of at least three replicates and the mean values are expressed 
as grams per 100 grams of the residual spent krill following oil extraction (dry 
weight basis). 
 
4.3.8. Statistical analysis   
The oil extraction experiments were triplicated (n = 3).  For each triplicate, 
at least three measurements were performed.  One-way independent measures 
analyses of variance (ANOVA) were used to examine the effects of all methods 
used.  Post-hoc analysis was conducted only in the presence of significant 
population differences (P0.05).  ANOVA statistical comparisons were conducted 
using KYPlot (KyensLab, Tokyo, Japan) with a significance level of P0.05.  
Tukey’s test (P0.05) was used to determine individual differences between 
treatments except for the differences of FA content between TRIG and PL where 
Student’s t-test was used (Figure 5). 
 
4.4 Results and Discussion 
4.4.1. Extraction efficiency 
Extraction of krill oil using the 2-step procedure resulted in similar 
(P0.05) efficiency as the 1-step procedure using a krill:solvent ratio of 1:6 
(Figure 2).  The extraction efficiency for the 1-step procedure increased (P0.05) 
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as the krill:solvent ratio increased, with 1:12 and 1:30 ratios having the greatest 
efficiencies.  Although these two krill:solvent ratios resulted in the highest 
(P0.05) efficiencies, they were similar (P0.05).  Therefore, krill:solvent ratio is 
a critical parameter for extraction efficiency.  Likely, if the krill:solvent ratio were 
increased in the 2-step extraction, the extraction efficiency would similarly 
increase.  However, 1-step extraction is simpler than the 2-step procedure; and 
therefore, 1-step extraction with acetone:ethanol (1:1, v:v) using 1:12 krill:solvent 
ratio is recommended.   
 
4.4.2. Determination of lipid classes with thin layer chromatography (TLC) 
and densitometry analysis 
Major lipid classes (triglycerides – TRIG, phospholipids – PL, and polar 
non-PL) of the extracted krill oils were identified using TLC (Figure 3), 
quantified by densitometry and presented as % of lipid class in total krill oil 
extracted (Figure 4).  The extraction procedure did not (P0.05) affect TRIG 
content in the extracted oils, which ranged 1.0-3.2% (Figure 4).  However, 
extraction procedure had an effect (P0.05) on PL content, with Folch, Soxhlet, 
and 1-step (1:6 krill:solvent ratio) extractions having the highest (P0.05) content 
of PL.  The PL content ranged from 20.4-32.7% (Figure 4).  A high PL content in 
krill oil has been described previously, with total PL at approximately 40% [5].  
The high PL content makes krill oil unique as compared to other dietary lipids.  
The TRIG content in fish oils is approximately 60% [39].   
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The major lipid class in all of the oils extracted from krill was the polar 
non-PL class (60%).  This class consists of the following lipid classes: 
cholesterol, mono- and di-glycerides, and the red pigment associated with krill oil 
(primarily astaxanthin).  The association of the red pigment with the polar non-PL 
class on the TLC plates made quantifying each class individually difficult, thus 
these classes were combined and accounted for as the polar non-PL class.  The 1-
step extraction with krill:solvent ratios greater than 1:6 and the acetone fraction 
from the 2-step extraction had the highest (P0.05) content of the polar non-PL 
class.  The densitometry results of the TLC plates coincided with the visual 
appearance of the oils.  The extractions that resulted in the highest content of the 
polar non-PL also had a deeper red color.  The differences in the polar non-PL 
class content should be of commercial interest.  It is possible that the extraction 
procedure could yield oil with lower cholesterol content, but higher antioxidant 
capacity.  Therefore, cholesterol content and total antioxidant capacity (as an 
indirect measure of astanxanthin content) were determined (see section 3.4 and 
3.5, respectively).  
 
4.4.3. Determination of fatty acid profile (FAP) of phospholipids (PL) and 
triglycerides (TRIG) with gas chromatography (GC) 
Following TLC analysis, TRIG and PL spots were scraped from the TLC 
plates and methylated for FAP by GC (Figure 5).  The TRIG had a higher 
(P0.05) content of myristic, palmitoleic, and oleic acid than PL (Figure 5A).  
Conversely, EPA and DHA were predominant (P0.05) in PL, contributing to 
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much higher (P0.05) content of total n-3 FA and unsaturated FA in PL than in 
TRIG (Figure 5B).  Consequently, the ratios of n6/n3 and saturated 
FA/unsaturated FA were lower (P0.05) in PL (Figure 5C). 
Consumption of ω-3 FA in a form of PL or TRIG has different health and 
physiological effects [41, 42].  Therefore, having EPA and DHA esterified as PL 
in krill oil has significant implications for human health.  The preferential 
esterification of EPA and DHA into PL is intriguing and has been noted 
previously [43].  However, available data comparing the benefits of consuming ω-
3 FA as krill oil compared to other sources is scarce.  Therefore, further studies 
are needed to compare and understand the nutritional value and health effects of 
krill oil versus other sources of n-3 FA. 
 
4.4.4. Cholesterol content in extracted krill oils 
The extraction procedures yielding oil with the highest (P0.05) content of 
polar non-PL (one-step extractions in Figure 4) did not have high cholesterol 
content (Figure 6).  The one-step procedures with krill:solvent ratios 1:9 had 
lower (P0.05) cholesterol content than acetone extract of the 2-step procedure.  
Cholesterol content of the 2-step, Folch, and Soxhlet extractions mimicked 
content of the polar non-PL (Figure 4), suggesting that the cholesterol content 
contributed more to the content of polar non-PL in these procedures than the one-
step procedures.   
In general, cholesterol content of krill is lower than shrimp, and slightly 
higher than fish [39].  Importantly, not only are sterols in krill composed of 
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cholesterol, but they also contain ~30% non-cholesterol sterols [44].  Non-
cholesterol sterols from both shellfish and plant sources have been shown to 
reduce cholesterol absorption in experimental studies [38].  Krill oil resulted in 
18% reduction in total serum cholesterol compared to 6% with fish oil in 
hyperlipidemic patients [19].  The hypolipidemic effects of seafood oils are not 
fully understood, but are significantly influenced by ω-3 PUFA.  Since krill oil is 
rich in ω-3 PUFA and contains non-cholesterol sterols, the hypolipidemic effects 
of krill oil could be additive.  
 
4.4.5. Antioxidant capacity (trolox equivalents – TE) of extracted krill oils 
The red color of krill oil is due to the carotenoid astaxanthin, a potent 
antioxidant.  Frozen krill contains 3-4 mg of carotenoids/100 g and astaxanthin is 
80% of the total carotenoids [18].  Aside from measuring the total antioxidant 
capacity of each extraction procedure as an indirect indicator of astaxanthin 
content, it is also useful information in terms of human health benefits.  It has 
been shown that astaxanthin decreases induced membrane oxidative injury to a 
greater degree than α-tocopherol, an antioxidant commonly used in food products.   
Oils extracted with the one-step procedure using 1:9 and 1:30 krill:solvent 
ratios as well as the ethanol extract of the two-step procedure had the highest 
(P0.05) antioxidant capacity (Figure 7).  Despite the highest (P0.05) content of 
polar non-PL (Figure 4), the acetone extract of the 2-step procedure had the 
lowest (P0.05) antioxidant capacity.  Therefore, the polar non-PL of the acetone 
extract may be predominately cholesterol.  The Folch extraction also yielded oil 
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with the lowest (P0.05) antioxidant capacity.  The antioxidant capacities of oils 
extracted with one-step procedures mimicked their respective contents of polar 
non-PL (Figure 4), suggesting that astaxanthin was the primary component of the 
polar non-PL in the oils extracted with one-step procedures.   
 
4.4.6. Crude protein, total fat, and ash content of the residual spent krill 
following oil extraction 
Proximate analysis performed on the residual spent krill that was 
recovered from the sediment following oil extraction and centrifugation (Figure 1) 
shows that the sediment was primarily composed of protein (~74 g/100 g, dry 
weight, Table 1).  The amount of protein in the residual spent krill was not 
(P0.05) affected by oil extraction procedure.  The lipid content decreased 
(P0.05) as the krill:solvent ratio increased from 1:9 to 1:30 in the one-step 
extraction.  The two-step extraction and one-step extraction using 1:12 and 1:30 
krill:solvent ratios resulted in the lowest (P0.05) lipid content in the residual 
spent krill.  Likewise, the one-step extraction using 1:30 krill:solvent ratio and 
two-step procedure also resulted in the lowest (P0.05) mineral content.  
However, the ash content in the residual spent krill was comparable to the ash 
content in whole krill prior to extraction (ash 17.4 g/100 g, dry basis, [45]).  
Therefore, the fluoride (F) content was likely high and would need to be reduced 
if the protein in the residual spent krill were to be recovered and used for 
human/animal consumption. 
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The proximate data clearly shows that there is high protein content in the 
residual spent krill; though ash (and likely F) is also high.  The protein could be 
recovered with the isoelectric solubilization/precipitation (ISP), while ISP also 
significantly reduces ash content [27, 45].  It has been shown that the proteins 
recovered from whole krill using ISP result in good quality heat-set gels [27].  
Therefore, a fuller utilization of krill as a human food would be possible by 
extracting oil as shown in the present study, followed by protein recovery by ISP 
for subsequent inclusion in human food products.   
93 
 
4.5 References 
 
1. Zhang X, and Beynen A (1992)  Increasing intake of soybean protein or 
casein, but not cod meal, reduces nephrocalcinosis in femals rats.  J.Nutr 
122: 2218-2225. 
2. Gigliotti, J. C., Smith, A. L., Jaczynski, J., & Tou, J. C. (2010). 
Consumption of krill protein concentrate prevents early renal injury and 
nephrocalcinosis in female Sprague-Dawley rats. Urological Research, in 
press. 
3. Schmiedl, A., Schwille, P.O., Bonucci, E., Erben, R.G., Grayczyk, A., and 
Sharma, V.  (2000).  Nephrocalcinosis and hyperlipidemia in rats fed a 
cholesterol- and fat-rich diet: association with hyperoxaluria, altered 
kidney and bone minerals, and renal tissue phospholipid-calcium 
interaction.  Urol Res, 28, 404-415. 
4. Schlemmer, C.K., Coetzer, H., Claassen, N., Kruger, M.C., Rademeyer, 
C., van Jaarsveld, L., & Smuts, C.M.  (1998).  Ectopic calcification of rat 
aortas and kidneys is reduced with n-3 fatty acid supplementation.  
Prostaglandins Leukot Essent Fatty Acids, 59, 221-227. 
5. Bottino, N. R. (1975). Lipid composition of two species of Antarctic krill: 
Euphausia superba and E. crystallorophias. Comparative Biochemistry 
and Physiology B, 50, 479-484. 
6. Nicol, S., James, A., & Pitcher, G. (1987). A first record of daytime 
surface swarming by Euphausia lucens in the Southern Benguela region. 
Marine Biology, 94, 7-10. 
94 
 
7. Suzuki, T., & Shibata, N. (1990). The utilization of Antarctic krill for 
human food. Food Reviews International, 6(1), 119-147. 
8. Food and Agriculture Organization of the United Nations. (2007). The 
state of world fisheries and aquaculture 2006. Rome, Italy: FAO Fisheries 
and Aquaculture Department. 
9. Smetacek, V., & Nicol, S. (2005). Polar ocean ecosystem in a changing 
world. Nature, 437, 362-368. 
10. Nicol, S., & Foster, J. (2003). Recent trends in the fishery for Antarctic 
krill. Aquatic Living Resources, 16(1), 42-45. 
11. Everson, I. (2000). Krill: Biology, ecology and fisheries. Oxford: 
Blackwell Science. pp. 384.  
12. Laws, R. M. (1985). The ecology of southern ocean. Amercican Scintist, 
73(1), 26-40. 
13. Hureau, J. C. (1985). Interaction between Antarctic and sub-Antarctic 
marine, freshwater and terrestrial organisms. In W. R. Siegfried, P. R. 
Condy, R. M. Laws, Antarctic Nutrient Cycles and Food Web. (pp. 626-
629). Berlin: Springer-Verlag. 
14. Grantham, G. J. (1977). The Southern Ocean: The utilization of krill. 
Southern Ocean Fisheries Survey Programme GLO/SO/7/3 (pp. 1-61). 
Rome (Italy): Food and Agriculture Organization. 
15. Gigliotti, J. C., Jaczynski, J., & Tou, J. C. (2008). Determination of the 
nutritional value, protein quality and safety of krill protein concentrate 
95 
 
isolated using an isoelectric solubilization / precipitation technique. Food 
Chemistry, 111(1), 209-214. 
16. Kolakowska, A., Kolakowski, E., & Szczygielski, M. (1994). Winter 
season krill (Euphausia superba Dana) as a source of n-3 polyunsaturated 
fatty acids. Die Nahrung, 38, 128-134. 
17. Harris, W.S., Kris-Etherton, P.M., and Harris, K.A.  (2008).  Intakes of 
long-chain omega-3 fatty acid associated with reduced risk for death from 
coronary heart disease in healthy adults.  Current Athereosclerosis 
Reports, 10. 
18. Yamaguchi, K., Miki, W., Toriu, W., Kondo, Y., Murakami, M., Konosu, 
S., Satake, M., Fujita, T. 1983. The composition of carotenoid pigments in 
the Antarctic krill Euphausia superba. Nippon Suisan Gakkaishi, 49(9), 
1411-1415. 
19. Bunea, R., El Farrah, K., & Deutsch, L. (2004). Evaluation of the effects 
of Neptune krill oil on the clinical course of hyperlipidemia. Alternative 
Medicine Review, 9(4), 420-428. 
20. Sampalis, F., Bunea, R., Pelland, M. F., Kowalski, O., Duguet, N., & 
Dupuis, S. (2003). Evaluation of the effects of Neptune krill oil on the 
management of premenstrual syndrome and dysmenorrhea.  Alternative 
Medicine Review, 8(2), 171-179. 
21. Sampalis, T. (2007). Krill and/or marine extracts for prevention and/or 
treatment of cardiovascular diseases arthritis, skin cancer diabetes, 
96 
 
premenstrual syndrome and transdermal transport. U.S. patent application 
number 20070098808. U.S. Patent and Trademark Office. 
22. Beaudoin, A., & Martin, G. (2004). Method of extracting lipids from 
marine and aquatic animal tissues. U.S. patent 6,800,299. U.S. Patent and 
Trademark Office. 
23. Anheller, J. E., Hellgren, L., Karlstam, B., & Vincent, J. (1989). 
Biochemical and biological profile of a new enzyme preparation from 
Antarctic krill Euphausia superba Dana suitable for debridement of 
ulcerative lesions. Archives of Dermatological Research, 281, 105-110. 
24. Dunford, N. T., Temelli, F., & LeBlanc, E. (1997). Supercritical CO2 
extraction of oil and residual proteins from Atlantic mackerel (Scomber 
scombrus) as affected by moisture content. Journal of Food Science, 
62(2), 289-294. 
25. Bruheim, I., Griinari, M., Tilseth, S., Banni, S., Cohn, J. S., & Mancinelli, 
D. (2008). Bioeffective krill oil compositions. U.S. patent application 
number 20080274203. U.S. Patent and Trademark Office. 
26. Carvajal, P. A., Lanier, T. C., & Macdonald, G. A. (2005). Stabilization of 
proteins in surimi. In J. W. Park, Surimi and Surimi Seafood, 2nd ed. (pp. 163-
225). Boca Raton (FL): Taylor and Francis Group. 
27. Chen, Y. C., & Jaczynski, J. (2007a). Gelation of protein recovered from 
whole Antarctic krill (Euphausia superba) by isoelectric solubilization / 
precipitation as affected by functional additives. Journal of Agricultural 
and Food Chemistry, 55, 1814-1822. 
97 
 
28. Jaczynski, J. (2007). Industrial bioreactor and method of use in continuous 
protein and lipid recovery system. U.S. patent application number 
20070281349. U.S. Patent and Trademark Office. 
29. Torres, J. A., Chen, Y. C., Rodrigo-Garcia, J., & Jaczynski, J. (2007). 
Recovery of by-products from seafood processing streams. In F. Shahidi, 
Maximizing the Value of Marine By-products. (pp. 65-90). Boca Raton 
(FL): CRC Press. 
30. Folch, J., Lees, M., & Sloane, S. (1957). A simple method for isolation 
and purification of total lipids from animal tissues. Journal of Biological 
Chemistry, 226, 497-509.  
31. Association of Official Analytical Chemists. (1995). Official Methods of 
Analysis. 16th ed., Gaithersburg, MD: Association of Official Analytical 
Chemists International. 
32. Chen, Y. C., Nguyen, J., Semmens, K., Beamer, S., & Jaczynski, J. 
(2006). Enhancement of omega-3 fatty acid content in rainbow trout 
(Oncorhynchus mykiss) fillets. Journal of Food Science, 71(7), C383-389. 
33. Chen, Y. C., Nguyen, J., Semmens, K., Beamer, S., & Jaczynski, J. 
(2007). Physicochemical changes in omega-3-enhanced farmed rainbow 
trout (Oncorhynchus mykiss) muscle during refrigerated storage. Food 
Chemistry, 104(3), 1143-1152.  
34. Chen, Y. C., Nguyen, J., Semmens, K., Beamer, S., & Jaczynski, J. 
(2008a). Effects of dietary alpha-tocopheryl acetate on lipid oxidation and 
alpha-tocopherol content of novel omega-3-enhanced farmed rainbow 
98 
 
trout (Oncorhynchus mykiss) fillets. LWT – Food Science and Technology, 
41(2), 244-253.  
35. Chen, Y. C., Nguyen, J., Semmens, K., Beamer, S., & Jaczynski, J. 
(2008b). Chemical changes in omega-3-enhanced farmed rainbow trout 
(Oncorhynchus mykiss) fillets during abusive-temperature storage. Food 
Control, 19(6), 599-608. 
36. Taskaya, L., Chen, Y. C., Beamer, S., Tou, J. C., & Jaczynski, J. (2009a). 
Compositional characteristics of materials recovered from whole gutted 
silver carp (Hypophthalmichthys molitrix) using isoelectric solubilization / 
precipitation. Journal of Agricultural and Food Chemistry, 57(10), 4259-
4266. 
37. Feeley, R. M., Criner, P. E., & Watt, B. K. (1972). Cholesterol content of 
foods. Journal of the American Dietetic Association, 61, 134-149. 
38. Vahouny, G. V., Connor, W. E., Roy, T., Lin, D. S., & Gallo, L. (1981). 
Lymphatic absorption of shellfish sterols and their effects on cholesterol 
absorption. American Journal of Clinical Nutrition, 34, 507-513. 
39. Tou, J. C., Jaczynski,
 
J., & Chen, Y. C. (2007). Krill for human 
consumption: nutritional value and potential health benefits. Nutrition 
Reviews, 65(2), 63-77. 
40. Kolakowska, A. (1991). The influence of sex and maturity stage of krill 
(Euphausia superba Dana) upon the content and composition of its lipids. 
Polish Polar Research, 12, 73-78. 
99 
 
41. Amate, L., Gil, A., & Ramirez, M. (2002). Dietary long-chain PUFA in 
the form of TAG or phospholipids influence lymph lipoprotein size and 
composition in piglets. Lipids, 37(10), 975-980. 
42. Matthews, S. A., Oliver, W. T., Phillips, O. T., Odle, J., Diersen-Schade, 
D. A., & Harrell, R. J. (2002). Comparison of triglycerides and 
phospholipids as supplemental sources of dietary long-chain 
43. Saether, O., Ellingsen, T. E., & Mohr, V. (1986). Lipids of North Atlantic 
krill. Journal of Lipid Research, 27, 274-285. 
44. Fricke, H., Gercken, G., Schreiber, W., Oehlenschlaeger, J. (1984). Lipid, 
sterol and fatty acid composition of Antarctic krill (Euphausia superba 
Dana). Lipids, 19(11), 821-827. 
45. Chen, Y. C., Tou, J. C., & Jaczynski,
 
J. (2009). Amino acid and mineral 
composition of protein and other components and their recovery yields 
from whole Antarctic krill (Euphausia superba) using isoelectric 
solubilization / precipitation. Journal of Food Science, 74(2), H31-39. 
 
 
100 
 
Figure 1. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Freeze-drying 
Laboratory batch centrifugation 
10,000 x g for 20 min at 4C 
Supernatant – extracted    
krill oil 
Extraction efficiency 
Lipid classes (TLC) 
Fatty acid profile of lipid classes (GC) 
Cholesterol content 
Antioxidant capacity 
Whole Krill 
Sediment – residual spent krill 
(protein, shell, etc.) 
Air-drying 
Proximate analysis                 
1- and 2-step extractions only 
(crude protein, total fat, ash) 
Air-drying 
Air-drying 
Dry clarified krill oil 
Residue and water 
discarded  
Clarification with 
chloroform:methanol (2:1, v:v) 
Separation funnel                
with 10% NaCl (as in Folch) 
1-step with 
acetone:ethanol (1:1, v:v) 
using 1:6, 1:9, 1:12, 1:30 
(krill:solvent, w:v) 
2-step with acetone 
followed by ethanol 
using 1:6 
(krill:solvent, w:v) 
 
Folch with 
chloroform:methanol 
(2:1, v:v) 
Soxhlet with 
petroleum 
ether 
101 
 
Figure 2. 
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Figure 3. 
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Figure 4. 
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Figure 5. 
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Figure 6. 
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Figure 7. 
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Figure 1.  A flow diagram for oil extraction from krill and subsequent analyses of the 
extracted oil and residual spent krill. 
 
Figure 2.  Extraction efficiency* of different solvent systems for extraction of oil from 
freeze-dried whole krill.  
* Different letters on the top of data bars indicate significant differences (Tukey’s test, 
P0.05) between mean values (SD, n = 3). 
 
Figure 3.  An example plate showing lipid classes resolved with thin layer 
chromatography (TLC) for krill oil extracted with one-step extraction using 1:12 
krill:solvent ratio (w:v) (triplicate).  TLC plates for krill oils extracted with different 
solvent systems were analyzed quantitatively with densitometry (Figure 4).  Lipid classes 
were isolated from TLC plates and analyzed for fatty acid profile (FAP) using gas 
chromatography (GC) shown in Figure 5. 
 
Figure 4.  Densitometry analysis* of TLC plates (an example of TLC plate is shown in 
Figure 3).  For two-step extraction, TLC plates with acetone and ethanol extracts were 
analyzed separately.  
*  Different letters on the top of data bars indicate significant differences (Tukey’s 
test, P0.05) between mean values (SD, n = 3) within a lipid class. 
 
Figure 5.  Major FA* in phospholipids (PL) and triglycerides (TRIG) of oil extracted 
from krill with one-step extraction using 1:12 krill:solvent ratio (w:v).  The PL, TRIG, 
and polar non-PL class were resolved with TLC (Figures 3 and 4).  The polar non-PL 
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class showed no detectable FA.  This class likely contained antioxidants including 
asthaxantin.  EPA – eicosapentaenoic acid (20:5n3), DHA – docosahexaenoic acid 
(22:6n3), n3 – -3 FA, n6 – -6 FA, UFA – total unsaturated FA, and SFA – total 
saturated FA.  
* Different letters on the top of data bars indicate significant differences (Student’s t-test, 
P0.05) between mean values (SD, n = 3) within the FA.  
 
Figure 6.  Cholesterol content in oil extracted from freeze-dried whole krill using 
different solvent systems.  
* Different letters on the top of data bars indicate significant differences (Tukey’s test, 
P0.05) between mean values (SD, n = 3). 
 
Figure 7.  Antioxidant capacity of oil extracted from freeze-dried whole krill using 
different solvent systems.  
* Different letters on the top of data bars indicate significant differences (Tukey’s test, 
P0.05) between mean values (SD, n = 3).  
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Table 1.  Crude protein*, total fat*, and ash content* of the residual spent krill following oil extraction with one- and two-step 
extraction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Different letters indicate significant differences (Tukey’s test, P0.05) between mean values (SD, n = 3) within the same row. 
 
 
 
   
 Extraction method 
 
1-step extraction with acetone:ethanol (1:1, v:v)                                                    
at different krill:solvent ratio (w:v) 2-step 
extraction 
 1:6 1:9 1:12 1:30 
Crude protein (g/100g, dry basis) 72.91.0 a 73.80.8 a 74.80.8 a 75.81.0 a 75.34.0 a 
Ash content (g/100g, dry basis) 17.70.7 a 17.30.5 a 17.90.5 a 16.10.6 b 15.60.4 b 
Total fat (g/100g, dry basis) 6.41.0 a 6.51.2 a 4.41.0 b 3.70.7 b 3.41.1 b 
110 
 
5.0     Chapter 3:  
 
 
Gigliotti, J.C., Turk, P., Livengood, R., Benedito, V., & Tou, J.C.  (2012) 
 
 
 
The Influence of Different Dietary Sources of Omega-3 Polyunsaturated Fatty Acids 
on Renal Health in Female Rats 
 
 
 
 
 
 
 
 
In preparation for submission to Kidney International 
 
111 
 
5.1 Background 
Results from Section 4 concluded that krill oil is rich in ω-3 PUFAs, and is a 
complex lipid composed of phospholipids and other lipid soluble pigments.  This unique 
lipid content has been the focus of advertisement for krill oil supplementation.  While 
research supports a benefit of krill oil supplementation in regards to various aspects of 
health, it is unclear how krill oil and other ω-PUFA sources may influence kidney health.  
In addition, residual ω-3 PUFA content may explain why certain protein sources (i.e 
soybean, KPC, codmeal, flaxseed, etc.) benefit renal health.   
 
5.2 Introduction 
Nephrocalcinosis (NC) is a form of renal disease characterized by increased 
deposition of Ca within kidney tissue.  The progression of NC is associated with 
detrimental changes in renal morphology and subsequent renal failure [1].  While NC 
affects various animal species (including humans), it is a serious issue in rodents where 
dietary components and gender impact its occurrence [2, 3].  The occurrence of NC in 
rats was a major consideration during the formulation of the current American Institute of 
Nutrition (AIN) rodent diet (AIN-93).  For the AIN-93 diet formulation, the occurrence 
of diet induced NC in rats was addressed through alterations in the dietary Ca and P 
content [3, 4].  While there is a clear relationship between the dietary mineral content and 
NC in rats [5, 6, 7), research suggests that changes in other dietary components can also 
influence NC.  Mayer et al. [8] found that changing the dietary protein source has a 
greater influence on NC than the dietary mineral content.  Further research has suggested 
that casein, which is commonly used in rodent diets, is more nephrocalcigenic [9, 10].  
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Aside from NC, changing the dietary protein source has been associated with benefits in 
other forms of renal disease as well [11, 12].   
The mechanism for how dietary protein can modulate renal health is still unclear.  
Some of the protein sources used in previous studies contained residual lipids from 
known sources of omega-3 polyunsaturated fatty acids (ω-3 PUFAs) [9, 10].  While the 
role of ω-3 PUFAs in human renal diseases in unclear [13], ω-3 PUFA supplementation 
has been reported to benefit rodent models of renal calcification [14, 15], 5/6 
nephrectomy [16, 17], diabetic renal disease [18], and polycystic kidney disease [19].  
Furthermore, corn oil was replaced with soybean in reformulation of the AIN-93 diet [20] 
and may also be responsible for the reduction in observed NC.  Soybean oil contains both 
essential fatty acids, the omega-6 polyunsaturated fatty acid (ω-6 PUFA) LA and the 
omega-3 (ω-3) PUFA ALA.  Corn oil is predominately the ω-6 PUFA LA, which 
provides a dietary ω-6 PUFA content suggested to be proinflammatory [21, 22].  
Inflammation and cellular damage are involved in the etiology of several renal diseases 
including NC [23, 24].  Therefore, increasing the consumption of the anti-inflammatory 
ω-3 PUFAs may influence the development of NC.   
In the current study, we determined the lipid class, and fatty acid composition of 
corn oil and different dietary sources of ω-3 PUFAs.  The characterized oils were then 
fed to young (28d), healthy female rats.  To our knowledge, this is the first study to 
compare the influence of different dietary sources of ω-3 PUFAs on renal health using 
non-diseased animals.  A primary aim of this study was to determine if changing the 
PUFA content of a casein-based diet can influence the development of NC in female rats.  
In turn, changing the dietary lipid content can also influence prostaglandin production 
[25-28], the activity of the proinflammatory transcription factor NFκB [21, 22, 28, 29], 
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and the expression of the proinflammatory, profibrotic chemokine transforming growth 
factor-beta 1 (TGF-β1) [30].  Aside from NC, inflammation and fibrosis are key 
components to the etiology of several renal diseases.  Therefore, the objectives of this 
study were: 
1. to determine if diets differing in ω-3 PUFA content influence the development of 
NC in healthy female rats fed a casein-based diet, 
2. to determine if diets differing in ω-3 PUFA content influence systemic 
prostaglandin production and the renal expression of COX-II, 
3. to determine if providing ω-3 PUFAs can influence the activity of NFκB and the 
expression of TGF-β in renal tissue.     
 
5.3  Materials and methods 
5.3.1 Selection of dietary oils 
Dietary sources of ω-3 PUFAs used in this study were flaxseed (FO), menhaden 
(MO), krill (KO), salmon (SO), and tuna oils (TO).  FO is considered the richest source 
of the essential ω-3 PUFA, ALA (Cunnane SC).  MO and SO are common sources of 
EPA and DHA in commercial fish oils supplements.  KO is a novel ω-3 PUFA source 
and has a similar fatty acid profile as MO.  However, KO has been suggested to be a rich 
source of phospholipid [10] as compared to most dietary oils which are presumed to be 
predominately triglycerides.  TO was chosen because it is considered a rich source of 
DHA, whereas other seafood ω-3 PUFA sources are generally higher in EPA.  CO was 
included because it is rich in the essential ω-6 PUFA, linoleic acid (LA, 18:2ω-3).  
Additionally, the inclusion of an oil rich in ω-6 PUFAs allows the comparison between 
the physiological effects of ω-6 and ω-3 PUFA rich oils.  FO, SO, and TO were 
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generously provided by Jedwards International (Quincy, MA).  MO was purchased from 
Omega Protein Inc. (Houston, TX), and the KO was purchased from Enzymotec USA 
Inc. (Morristown, NJ).  All oils were of commercial feed grade, and were kept at 4°C in 
the dark.     
 
5.3.2 Lipid analysis of dietary oils 
Quantifying lipid classes 
Thin-layer chromatography (TLC) was performed to identify and quantify the 
different lipid classes.   Approximately 1mg of each oil was dissolved in 
chloroform:methanol (1:1; v:v) and spotted  onto Whatman K6F Silica plates with 60Å 
pore sizes, (Cobert Associates, MO).  Silica plates were developed in a 
hexane:ether:acetic acid  (80:20:1.5; v:v:v) solvent.  Following development, plates were 
air-dried for 5 min and visualized using a Fluorchem 8000 densitometer using 
transluminating white light (Alpha Innotech Corp, CA).  Plate images were captured 
using a camera interfaced to PC and the lipid classes were quantified using the spot 
densitometer tab in the Fluorchem (version 1.0) computer program.  Total 
glycerophospholipid (PL) and triacylglyceride (TAG) lipid classes were identified using 
RF values obtained by comparison to the standards soybean lecithin (Fisher Scientific, 
PA) and triolein (Sigma-Aldrich, MO), respectively.  Due to the pigmentation of KO, 
which is presumably astaxanthin, lipid classes located between the PL and TAG spots 
were quantified and summed together collectively as polar, non-phospholipids 
(representative image in Figure 1).  Data from the TLC plates are presented as a 
percentage of the total pixel count of the lane.     
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Determining fatty acid composition 
Fatty acid methyl esters (FAMEs) were prepared from the dietary oils using the 
procedure described by Fritsche and Johnston [31].  Briefly, 4 ml of a 4% 
H2SO4/methanol solution was added to 20-30 mg of oil.  The methylation reaction was 
carried out by heating at 90ºC for 1 h and was terminated by the addition of water.  
FAMEs were then isolated in chloroform, dried under nitrogen gas, and resuspended to a 
known concentration (2-5mg/ml) in isooctane.  FAMEs were analyzed by gas 
chromatography (GC, CP-3800 Varian), using nitrogen as the carrier gas.  GC setting 
consisted of an initial temperature of 140
o
C for 5 min followed by an increase of 1
o
C per 
min to a final temperature of 220
o
C.   Fatty acids were identified as FAMEs by 
comparing retention times to a FAME 37 standard (Supelco, PA) and presented as 
percent of total peak area counts corrected for isooctane.   
 
5.3.3 Diet formulation 
Experimental diets (Table 1) were based on the standard semi-purified AIN-93G 
formulation.  Diets were formulated to be 12% (by weight), high fat diets with the lipid 
source supplied as either CO, FO, MO, KO, SO, or TO.  MO and KO diets consisted of a 
blend of 11.8% test oil + 0.2% CO in order to meet the recommendation for LA in 
growing rats [32].  The lipid dose (12% by wt) is based on levels of oil achievable in the 
human diet (approximately 27% caloric intake); whereas much higher lipid inclusions 
have been used previously.  Diets were flushed with nitrogen gas, vacuum sealed in 1 kg 
packages, and stored in the dark at -20°C until fed. 
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5.3.4 Animal Study 
All animal procedures were conducted in accordance with the guidelines set forth 
by the National Research Council for the Care and Use of Laboratory Animals and 
approved by the Animal Care and Use Committee at West Virginia University. 
Young (28 d), female Sprague-Dawley rats were obtained from Hilltop Lab 
Animals Inc. (Scottdale, PA).  Female Sprague-Dawley rats were chosen due to their 
susceptibility to diet induced renal damage [2].  Upon arrival, rats were individually 
housed in metabolic cages, and maintained in a room at 21
o
C with a 12 h light/dark cycle.  
During a 7 d acclimation period, animals were given ad libitum access to deionized 
distilled water (ddH2O) and AIN-93G diet (Harklan Teklad, IN).  Following the 7 d 
acclimation period, rats were then randomly assigned (n = 10 rats) to one of the six 
experimental diets. The rats were provided (14.75 ± 0.75g), to prevent variation in total 
caloric intake, and fresh diets were supplied daily throughout the 8 week study.  Body 
weights and diet and ddH2O consumption was recorded throughout the study. 
 
5.3.5 Determining kidney mineral content 
At the end of the 8 week feeding study, rats were euthanized by CO2 inhalation.  
Both kidneys were excised, trimmed, decapsulated, and weighed separately.  After no 
bilateral difference in left and right kidney weights was determined, the left kidney was 
divided transversely and both halves were frozen at -80ºC until analyzed.   
To determine kidney mineral content, half of the left kidney was ashed in a muffle 
furnace (Lindberg 515A2, WI) at 550
o
C for 24 h.   Ashed samples were dissolved in 2 
mL of 70% nitric acid, filtered through Whatman no. 1 paper, and diluted to a final 
volume of 25 mL in ddH2O.  The Ca and P content of the kidney samples (mg/g kidney 
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tissue) were determined using inductively coupled plasma spectrometry (ICP) (model 
P400, Perkin Elmer, Shelton, CN). 
 
5.3.6 Kidney histology 
A center sagittal section was removed from the right kidney and immediately 
fixed in 10% formalin solution (VWR, PA) for histological evaluation.  Tissues were 
dehydrated through a series of increasing ethanol concentrations in ddH2O to xylene and 
embedded in paraffin.  3µm sections from each block were stained with hematoxylin and 
eosin with appropriate staining control tissue.  Histologic parameters evaluated included 
glomerular hypercellularity and matrix deposition, arteriolosclerosis, tubular dilation, 
tubulointerstitial fibrosis, interstitial inflammation, and interstitial matrix deposition or 
calcification.  All slides were analyzed under a Nikon TE 2000-S light microscope 
(Nikon Instruments, NY) by two trained individuals who were blinded to the treatments.  
Representative images presented were captured using a PC interfaced with Q-Capture 
imaging software (Quantitative Imaging Corporation, BC, Canada). 
 
5.3.7 Kidney fatty acid composition 
To determine the fatty acid composition of the kidneys, total lipid was extracted 
from the remaining half of the left frozen kidney following a modified method of Bligh 
and Dyer [33].   Briefly, ~400 mg of frozen renal tissue was homogenized in Tris/EDTA 
buffer and mixed with a chloroform:methanol:acetic acid (2:1:0.15 v/v/v) solution.   After 
centrifugation at 900 x g for 10 minutes at 10
o
C, the bottom chloroform layer was 
collected. The collected chloroform was filtered through 1-phase separation filters, dried 
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under N2 gas, and the extracted lipid samples were then methylated and quantified as 
described above for the fatty acid analysis of dietary oils. 
 
5.3.8 RNA isolation and real-time PCR analysis 
A portion of the right kidney was frozen in liquid nitrogen and stored at -80oC 
until processed for RNA isolation.  Total renal RNA was extracted from ~100 mg of 
frozen tissue following the Total RNA Isolation procedure of the mirVana miRNA 
Isolation Kit (Ambion, TX).  Isolated RNA integrity was visualized on a 1.5% agarose 
gel, and isolate RNA concentration was quantified by spectrophotometry (Thermo 
Scientific, DE).  After DNase treatment of the isolated RNA (Applied Biosystems, CA), 
total mRNA was amplified using the Superscript III First Strand Synthesis assay with 
oligo dT primers (Invitrogen, CA).     
Primers were designed for rat COX-II (Ptgs2, NM_017232), TGF-β (Tgfb1, 
NM_021578), and the housekeeping gene GAPDH (Gapdh, NM_017008.3) using the 
Primer3 program [34] and respective mRNA sequences obtained from NCBI.  Forward 
and reverse primers for COX-II (PTGS2) were 5’ CGGAGGAGAAGTGGGTTTTAG 3’, 
and 5’ TGAAAGAGGCAAAGGGACAC 3’ respectively.  Forward and reverse primers 
for TGF-β (Tgfb1) were 5’ GCCTGAGTGGCTGTCTTTTG 3’ and 5’ 
CCCTGTATTCCGTCTCCTTG 3’ respectively.  Primer efficiencies were determined on 
pooled RNA samples serially diluted in ddH2O up to 1:10000.   
PCRs consisted of 2.5µl of SYBR
®
 Green Master Mix (Applied Biosystems, CA), 
1µl of cDNA, 1µl of respective forward and reverse primers, and 0.5µl of ddH2O for a 
total reaction volume of 5µl.  The thermal profile consisted of 50°C for 2 minutes, 95°C 
for 10 minutes, and then 40 cycles of 95°C for 15 seconds and 60°C for 1 minute.   Data 
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was analyzed as described by Pfaffl [35], and normalized to GAPDH expression.  Data is 
presented as relative expression compared to rats fed (CO). 
 
5.3.9 Isolation of nuclear proteins and measurement of NFκB activation  
A portion of the right kidney (~300mg) was processed for isolation of nuclear 
proteins using a commercially available nuclear protein extraction kit (Active Motif, Ca).  
The protein content of the nuclear extract was determined using a commercially available 
protein determination assay based on the Bradford method (Cayman Chemical, MI).  The 
activation of NFκB was determined using the TransAM NFKB p65 transcription factor 
assay kit (Active Motif, CA).  Nuclear protein (10µg) was used for the assay, and results 
were calculated as a percentage of NFκB activity seen in rats fed CO.     
  
5.3.10 Serum and urinary measures of renal function and health   
At the end of the 8 week feeding study, rats were euthanized by CO2 inhalation 
and trunk blood was collected.  Blood samples were maintained at 4ºC for 15 min, and 
then centrifuged for 10 min at 1500 X g for serum isolation.  Serum measures of kidney 
function included: total protein, albumin, blood urea nitrogen (BUN), creatinine, Ca, and 
P.  Serum measures of kidney function were determined by colorimetric assays using a 
commercially available Vet-16 rotor quantified by a Hemagen Analyst automated 
spectrophotometer (Hemagen Diagnostics Inc., MD).     
Urinary volume was recorded and collected throughout the study.  Urinary 
measures of kidney function were performed on pooled urine samples collected during 
the final week of the study and included urinary: Ca and P content, creatinine, albumin, 
PGE2 and pH.  Urinary Ca and P content was determined by diluting the urine 1:40 in 
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ddH2O, and then analyzed by ICP.  Urinary creatinine was determined using a 
colorimetric assay (Cayman Chemical, MI).  Urinary albumin (Alpco, NH) and PGE2 
metabolite content (Cayman Chemical, MI) was determined using commercially 
available assays.  Urinary pH was determined using a standard pH meter (Beckman, CA).  
Glomerular filtration rate (GFR) was estimated by measuring creatinine clearance (CrC) 
determined as: CrC = (UC/SC) X V, where UC is urinary creatinine concentration, SC is 
serum creatinine concentration, and V is the volume of urine excreted per minute. 
 
5.3.11 Statistical analysis 
The animal feeding study was analyzed as a completely randomized design, with 
n=10 rats per diet treatment.  One-way analysis of variance (ANOVA) was used to 
determine differences among rats fed the different diets, while a nonparametric rank 
analysis was performed on data not normally distributed.  Post-hoc analysis was 
performed using Tukey’s test, and all statistical analysis was performed using Sigma Stat 
3.1 (Systat Software Inc., San Jose, CA).  Differences were considered significant at 
P<0.05. 
 
5.4 Results 
5.4.1 Lipid Analysis of Dietary Oils 
All dietary oils used in the study were predominately TAG (>65%) with the 
exception of KO.  The lipid content of KO was unique in that it was primarily composed 
of PLs and polar, non-phospholipid classes (Figure 1).  The plant oils were abundant in 
the essential fatty acids LA and ALA, and devoid of the long chain PUFAs AA, EPA and 
DHA.  The seafood sources of ω-3 PUFAs all contained EPA and DHA, and had ω-6:ω-3 
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of at least 1:10.  However, absolute amounts and ratios of EPA and DHA varied among 
sources.  KO and SO had the highest EPA content, while and TO had the highest DHA 
content (Table 2).   
 
5.4.2 Kidney mineral content 
Rats fed KO had heavier (P<0.001) relative kidney weights compared to rats fed 
FO or MO (Table 3).  Rats fed KO had the highest kidney Ca content (P<0.001) and 
higher kidney P content compared to rats fed MO (P=0.03). 
 
5.4.3 Kidney histology 
All rats fed KO displayed tubular calcification, dilation, tubulointerstitial changes 
(specifically fibrosis), and interstitial inflammation (Figure 2).  Sparse fibrosis and 
interstitial inflammation was observed among all treatment groups.  However, rats fed FO 
also displayed a higher occurrence of these two conditions compared to the other dietary 
groups.  No differences in glomerular morphology or arteriolosclerosis were observed 
among the treatment groups.      
 
5.4.4 Kidney fatty acid composition 
No differences were found in total lipid content among treatment groups (P=0.4).  
The fatty acid content of the kidneys was similar to the fatty acid composition of the diet.  
Rats fed CO had a tissue ω-6:ω-3 ratio greater than 30:1, the highest tissue ω-6 content, 
and the lowest EPA and DHA content.  All rats provided ω-3 PUFA sources had an ω-
6:ω-3 ratio less than 3:1.  Among ω-3 PUFA sources, renal tissue from rats fed FO had a 
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similar LA content as found in rats fed CO, the lower renal EPA and DHA content, and 
the highest total ω-6 content as compared to rats fed the marine ω-3 PUFA oils (Table 4).                
 
5.4.5 Real-time PCR analysis 
COX-II expression was lower in all rats provided ω-3 PUFAs as compared to rats 
fed CO (Figure 3).  The expression of COX-II was the lowest in rats fed SO or TO diets, 
which was 45 and 16% lower than in rats fed CO, respectively.  COX-II expression in 
rats fed KO was approximately half (55%) of that of CO fed rats, while MO and FO fed 
rats expressed COX-II at 85 and 78% of that in rats fed CO, respectively. 
Feeding ω-3 PUFAs also resulted in reduced expression of TGF-β (Figure 4).  
Rats fed KO, SO, and TO had the lowest TGF-β expression, which as approximately 45% 
of that in rats fed CO.  Rats fed FO and MO had TGF-β expression at 84 and 80% 
compared to rats fed CO, respectively.   
 
5.4.6 NFκB activation  
NFκB activity in rats fed SO and TO was approximately 17 and 11% of that 
found in rats fed CO.  The measured NFκB activity appeared similar in rats fed CO, MO 
and KO.  Rats fed FO had the highest apparent NFκB activity, which was at 30% higher 
than all other groups (Figure 5). 
 
5.4.7 Serum and urinary measures of renal function and health 
There were no differences in serum measures of kidney function of creatinine, 
phosphorus, Ca, and total protein between rats fed the different diets.  Rat fed SO had 
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higher (P=0.04) BUN content compared to rats fed CO, however this difference was 
absent when BUN was corrected for creatinine (Table 5).   
There were significant differences in the urinary measures of kidney health and 
function.  Rats fed MO and FO had greater (P=0.009) urinary excretion of Ca compared 
to rats fed TO, while rats fed KO had the highest (P<0.001) urinary excretion of P and 
greatest reduction in urinary pH (P<0.001).  These results occurred in the absence of 
differences in urinary volume (P=0.9) and albuminuria (P=0.4)  (Table 6).   
There was also an apparent differences in urinary excretion of PGE2 during the 
final week of the study (Figure 6).  Rats provided seafood sources of ω-3 PUFAs (MO, 
KO, SO, and TO) had <50 % lower excretion of urinary PGE2 compared to rats fed FO or 
CO. 
 
5.5 Discussion 
5.5.1 Nephrocalcinosis and associated damage 
A major objective of this study was to determine if changing the PUFA content of 
casein-based diets influences the development of NC in female rats.  Differences in 
kidney weights provided initial evidence for the presence of NC.  Previous studies have 
found that heavier kidney weights were positively correlated with the kidney Ca content 
[5, 36].  Unexpectedly, the heaviest kidney weights were observed in rats fed a source of 
ω-3 PUFAs (KO), but not in rats fed the ω-6 PUFA rich CO.  The presence of NC in rats 
fed KO was confirmed by elevated renal Ca content and histological identification of 
mineral deposits.  In addition, histological evaluation showed tubular dilation, 
tubulointerstitial changes (namely fibrosis), and/or interstitial inflammation in all rats fed 
KO.  These structural changes are common with advanced renal mineralization [37, 38].  
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Fibrosis and interstitial inflammation are common in a numerous forms of advanced renal 
diseases, and supports the involvement of NC in the initiation of renal failure [1].   
NC, and its associated renal disease, can be generated experimentally by 
increasing dietary P content [5, 37, 38].  In the current study, the same basal diet was 
used for all diets fed and therefore contained equal amounts of inorganic P (0.03% by 
weight).  However, rats fed KO had elevated urinary P content and acidity, a urinary 
composition typically associated with increased P intake [5, 6].  Further analysis revealed 
that the KO diets had an increased P content (0.46% vs 0.3%).  Characterization of the 
oils showed that KO had a high PL content.  Therefore, we concluded that the observed 
NC in rats fed KO was due to elevated P intake in the form of PLs.  This conclusion was 
supported by a previous study, where rats fed diets high in P (0.4-0.6%)  had similar renal 
Ca content [36].   
It was unexpected that rats fed the EPA rich KO, and not the ω-6 PUFA rich CO, 
developed NC.  This contradicts previous findings where EPA retarded calcium 
gluconate induced renal mineralization in both male and female rats [14, 15].  However, 
calcium gluconate induces NC through hypercalcemia and hypercalciuria; a form of NC 
that likely differs in etiology as compared to P induced NC [39].  Therefore, the results 
presented here suggest that ω-3 PUFA supplementation does not influence P induced NC.         
 
5.5.2 Renal fatty acid composition and prostaglandin production 
Another aim of this study was to determine if changing the PUFA content of the 
tissue can influence inflammatory gene expression in non-diseased induced animals.  To 
our knowledge, this is the first study comparing the influence of multiple dietary sources 
of PUFAs on renal fatty acid composition and health in non-diseased animals.  Our diets 
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were high fat (12% vs. 7%), but remained lower than high fat diets used in other studies.  
The increased lipid content was chosen to amplify effects while maintaining a 
physiologically relevant dose. 
In general, the fatty acid composition of renal tissue was similar to the fatty acid 
composition of the diet.  Rats fed ω-3 PUFAs had a renal ω-6:ω-3 ratio ten times lower 
than that found in rats fed CO.  Among rats fed ω-3 PUFA rich oils, rats fed FO had the 
highest renal ω-6 PUFA content and renal ω-6:ω-3 ratio.  Ogborn et al., [19] reported that 
rats fed a chow based diet with a 10% inclusion of whole flaxseed had reduced renal Ca 
content.  In our study, rats fed FO had a higher renal EPA and DHA content than rats fed 
CO.  However, these levels were less than half that found in rats fed seafood based ω-3 
oils.  Mammalian conversion of ALA to EPA and DHA is considered an inefficient 
process, and is the basis for recommendation for increased fatty fish consumption.  Based 
on our results, providing ω-3 PUFAs as ALA was inefficient at saturating renal tissue 
EPA and DHA as compared to feeding rats seafood based oils rich in EPA and DHA. 
The PUFA content of renal tissue is important given the role of PUFAs as 
substrates for prostaglandin production.  PGE2 is crucial for renal homeostasis [40] and 
therefore, the changes in tissue PUFA observed in our study may influence prostaglandin 
production and renal health.  Rats provided the seafood sources of ω-3 PUFAs (MO, KO, 
SO, and TO) had over 50% reduction of urinary PGE2 excretion compared to rats fed CO 
and FO.  Increased tissue EPA content can compete with AA for membrane 
incorporation, and this can affect substrate availability for COX mediated prostaglandin 
production.  This is supported by previous studies, where feeding rats a mixture of MO 
and CO led to a reduction in PGE2 production [23] and increase in PGE3 [41] production 
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by renal medullary tissue.  Therefore, the decreased PGE2 excretion in these rats could be 
the result of altered substrate availability and increased PGE3 production.   
 
5.5.3 Renal molecular analysis 
The lower PGE2 excretion in rats provided ω-3 PUFAs could also be a 
consequence of reduced renal COX-II expression.  In vitro studies suggest that ω-3 
PUFAs can influence COX-II expression, and this occurs through mediating the activity 
of the NFκB transcription factor [29].   In the current study, rats provided ω-3 PUFAs had 
reduced renal COX-II expression and NFκB activity as compared to rats fed CO.  This 
difference was most pronounced in rats fed SO and TO.  In vitro studies suggest that 
NFκB activation is sensitive to ω-3 PUFAcontent, especially DHA [29, 42].  In our study, 
TO had the highest DHA content which may explain the reduced NFκB activation.  Rats 
fed SO also had lower renal NFκB activity, despite having a lower oil and tissue DHA 
content.  Preliminary studies suggest that DHA bioavailability is higher in rats fed SO, 
which may partly explain these results (unpublished data).  We expected the NFκB 
activity in rats fed FO and KO to be elevated, due to the occurrence of inflammation in 
these animals.  In agreement, rats fed FO had greater than a 30% increase in NFκB 
activity compared to all other rats.  NFκB is considered a master regulator of the 
inflammatory response [43, 44], and may explain the mild morphological changes 
observed in rats fed FO.  However, there was no apparent increase in NFκB activity in 
rats fed KO.  As previously discussed, the damage observed in rats fed KO was likely due 
to the P induced NC.  An in vitro study suggested that the inflammatory signaling 
induced by calcium-phosphate crystals is mediated by transcription factors other than 
NFκB [39].   
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The renal expression of TGF-β was also of interest, since it is considered a key 
signaling molecule in renal fibrosis [45].  Furthermore, previous research has shown that 
renal TGF-β expression is decreased with ω-3 PUFA supplementation in rodent models 
of lupus [30].  In our study, rats fed KO, SO, and TO had a 45% reduction in TGF-β 
expression compared to rats fed CO.  However, this reduction in TGF-B expression did 
not reflect the occurrence of observed renal tubulointerstitial fibrosis.  Fibrotic processes 
are complex, and consist of various cell types and signaling molecules.  Therefore, it is 
unlikely that the degree of interstitial fibrosis observed here is due to variations in TGF-β 
expression alone.   
In summary, feeding high fat diets differing in PUFA content appears to influence 
renal composition and health in non-diseased female rats.  All diets rich ω-3 PUFAs led 
to an increase in renal ω-3 PUFA content; however, the absolute amount varied among 
sources.  Rats fed the seafood sources of ω-3 PUFAs excreted > 50% less PGE2 than rats 
fed CO and FO, which could be related to the lower tissue ω-6:ω-3 ratio and suppressed 
renal COX-II expression in these animals.  Additionally, altered NFκB activity and renal 
expression of COX-II and TGF-β suggests that the potential anti-inflammatory activities 
differ between dietary ω-3 PUFA sources. However, increased tissue ω-3 PUFA content 
did not prevent the development of P induced NC and associated renal damage in rats fed 
KO.  Therefore, we conclude that changing the dietary PUFA content can have profound 
influence on renal health in rats.  This, and other data, suggests that the kidneys are 
heavily influenced by dietary composition, and that renal health could become 
compromised with the consumption of an improper diet.    
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Figure 3.  Renal COX-II (PTGS-2) expression 
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Figure 4.  Renal TGF-β expression 
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Figure 5. Renal NFκB activity. 
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Figure 6.  Urinary excretion of PGE2 
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Figure 1.  Representative image and quantification of lipid classes in PUFA oils of 
interest.  Spots were quantified by densitometry and data expressed as % of total lipid 
detected on TLC plate.  Data presented as mean ± SEM. 
TRG = triglyceride, PL = phospholipid. 
 
Figure 2.  Representative images of identified changes in renal morphology.  Data is 
represented as proportion of animals displaying morphological changes (n=10). 
 
Figure 3.  Expression of PTGS-2 (COX-II) in renal tissue of rats fed diets varying in 
PUFA content.  Data is reported as a percentage of expression found in rats fed corn oil. 
 
Figure 4.  Expression of TGF-β in renal tissue of rats fed diets varying in PUFA content.  
Data is reported as a percentage of expression found in rats fed corn oil. 
 
Figure 5.  Activation of NFκB in renal tissue nuclear extracts of rats fed diets varying in 
PUFA content.  Data is reported as a percentage of expression found in rats fed corn oil. 
 
Figure 6.  Urinary excretion of PGE2 in rats fed diets varying in PUFA content.  Data is 
reported as a percentage of expression found in rats fed corn oil. 
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Table 1.  Experimental Diet Compositions  
 
Ingredients (g/kg diet) AIN-93G Corn Flax Menhaden
b
 Krill
b
 Salmon Tuna 
Soybean Oil 70.0 - - - - - - 
Corn Oil - 120.0 - 2.0 2.0 - - 
Flaxseed Oil - - 120.0 - - - - 
Salmon Oil - - - - - 120.0 - 
Menhaden Oil - - - 118.0 - - - 
Tuna Oil - - - - - - 120.0 
Krill Oil - - - - 118.0 - - 
Casein 200.0 200.0 200.0 200.0 200.0 200.0 200.0 
L-Cysteine 3.0 3.0 3.0 3.0 3.0 3.0 3.0 
Corn Starch 397.5 347.5 347.5 347.5 347.5 347.5 347.5 
Maltodextrin 132.0 132.0 132.0 132.0 132.0 132.0 132.0` 
Sucrose 100.0 100.0 100.0 100.0 100.0 100.0 100.0 
Cellulose 50 50 50 50 50 50 50 
Mineral Mix
a
 35 35 35 35 35 35 35 
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Vitamin Mix
a
 10 10 10 10 10 10 10 
Choline Bitartrate 2.5 2.5 2.5 2.5 2.5 2.5 2.5 
Antioxidant (TBHQ)
 
0.014 - - - - - - 
a
 Based on the AIN-93G vitamin and mineral mixes [7]. 
b
 Diets formulated for 118 g of test oil + 2 g corn oil to meet LA requirements. 
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Table 2.  Fatty acid composition of experimental oils 
 
Fatty Acid (%) Corn Flax Menhaden Krill Salmon  Tuna 
14:0 - - 12.3 5.1 10.3 3.7 
16:0 10.5 4.9 24.3 31.4 21.9 16.7 
16:1 - - 17.6 3.8 12.7 5.2 
18:0 1.6 2.96 3.1 1.9 2.9 4.4 
18:1 26.8 18.7 12.1 16.7 16.8 14.4 
18:2 (ω6) 57.8 15.5 0.7 1.9 4.0 1.7 
18:3 (ω3) 1.0 55.9 3.1 1.3 1.4 0.7 
20:4 (ω6) - - - - - 1.9 
20:5 (ω3) - - 3.9 20.3 14.4 8.6 
22:6 (ω3) - - 3.3 5.9 3.5 24.8 
EPA:DHA ND ND 3:1 3:1 4:1 1:3 
Total ω6 58 16 0.7 2 4 3.6 
Total ω3 1 56 15 27 19 34 
ω6:ω3 59:1 1:4 1:23 1:14 1:5 1:10 
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Table 3.  Relative kidney weights, and renal Ca and P content 
 
 Corn Flaxseed Menhaden Krill Salmon Tuna P 
Kidney weight (mg/100g BW) 837.2 ± 24.5
ab
  749.1 ± 16.6
b
 785.3 ± 37.9
b
 918.7 ± 18.3
a
 823.7 ± 22.1
ab
 830.7 ± 12.7
ab
 <0.001 
Kidney Ca content (mg/g) 0.21 ± 0.02
b
 0.21 ± 0.02
b
 0.21 ± 0.02
b
 0.58 ± 0.12
a
 0.18 ± 0.02
b
 0.18 ± 0.02
b
 <0.001 
Kidney P content (mg/g) 2.40 ± 0.06
ab 
2.43 ± 0.05
ab 
2.31 ± 0.09
b 
2.88 ± 0.27
a 
2.47 ± 0.03
ab 
2.49 ± 0.03
ab 
0.03 
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Table 4.  Total lipid and fatty acid content of kidney tissue 
 
  Corn Flax Menhaden Krill Salmon  Tuna 
Kidney lipid content (mg/g) 43.3 ± 8.8 44.6 ± 4.6 42.7 ± 2.7 36.2 ± 5.3 31.8 ± 3.5 35.0 ± 5.1 
Fatty Acid (%)       
16:0 23.53 ± 0.24 22.42 ± 0.25 25.30 ± 0.44 25.05 ± 0.56 26.64 ± 0.57 28.06 ± 0.55 
16:1 - 1.10 ± 0.07 2.23 ± 0.16 1.58 ± 0.10 2.16 ± 0.14 2.05 ± 0.21 
18:0 13.51 ± 0.41 13.93 ± 0.33 13.81 ± 0.45 14.81 ± 0.20 15.80 ± 0.43 15.20 ± 0.57 
18:1 11.93 ± 1.19 13.80 ± 0.54 11.86 ± 0.65 11.83 ± 0.45 13.39 ± 0.63 13.92 ± 0.80 
18:2 (ω6) 11.85 ± 0.89 11.68 ± 0.28 3.18 ± 0.23 2.77 ± 0.12 2.39 ± 0.19 2.17 ± 0.13 
18:3 (ω3) - 4.01 ± 0.24 - - - - 
20:4 (ω6) 20.95 ± 1.04 10.83 ± 0.32 13.11 ± 0.36 9.90 ± 0.48 11.96 ± 0.58 14.57 ± 1.09 
20:5 (ω3) - 4.52 ± 0.26 6.73 ± 0.36 9.69 ± 0.54 8.86 ± 0.32 5.08 ± 0.27 
22:6 (ω3) 1.05 ± 0.08 1.81 ± 0.06 6.54 ± 0.36 6.16 ± 0.37 4.71 ± 0.15 5.56 ± 0.15 
EPA:DHA 0:1 3:1 1:1 2:1 2:1 1:1 
Total ω6 33 23 16 13 14 17 
Total ω3 1 10 13 16 13 11 
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ω6:ω3 33:1 2:1 1:1 1:1 1:1 2:1 
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Table 5.  Serum measures of kidney function 
 
 Measurement Corn Flax Menhaden Krill  Salmon  Tuna P 
BUN (mg/dL) 10.7 ±  1.3
b
 10.7 ± 1.3
ab
 13.6 ± 0.9
ab
 12.2 ± 0.7
ab
 15.2 ± 0.9
a
 13.1 ± 0.6
ab
 0.04 
Serum creatinine (mg/dL) 0.5 ± 0.04
 
0.5 ± 0.02
 
0.5 ± 0.04 0.4 ± 0.05 0.7 ± 0.09
 
0.6 ± 0.08
 
0.2 
BUN/Creatinine 22.7 ± 1.7 26.1 ± 2.6 33.5 ± 5.4 30.6 ± 3.8 23.4 ± 4.3 27.7 ± 4.7 0.5 
Serum phosphorus(mg/dL) 9.4 ± 0.7 10.1 ± 0.3 10.4 ± 0.6 9.7 ± 0.4 9.8 ± 0.5 10.1 ± 0.2 0.8 
Serum calcium (mg/dL) 13.4 ± 1.0 13.6 ± 0.5 13.9 ± 1.0 14.6 ± 1.3 13.0 ± 0.5 12.6 ± 0.3 0.7 
Serum protein (g/dL) 5.8 ± 0.4 6.1 ± 0.3 6.3 ± 0.1 6.2 ± 0.3 6.3 ± 0.2 6.0 ± 0.2 0.7 
CrC (ml/min) 0.65 ± 0.1 0.59 ± 0.1 0.71 ± 0.08 0.80 ± 0.2 0.48 ± 0.2 0.99 ± 0.2 0.3 
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Table 6.  Urinary measures of kidney health and function during the final week of the study 
 
Measurement Corn Flax Menhaden Krill Salmon Tuna P 
Urinary output (ml/d) 4.3 ± 0.7 4.0 ± 0.6 4.2 ± 0.6 3.5 ± 0.7 4.0 ± 0.6 4.6 ± 1.0 0.9 
Urinary albumin (mg/7d) 3.3 ± 1.4 4.3 ± 1.2 2.1 ± 0.5 6.6 ± 3.1 3.0 ± 1.0 2.5 ± 0.7 0.4 
Urinary Ca (final) (mg/7d) 4.7 ± 2.1
ab 
4.0 ± 0.9
a 
4.7 ± 1.5
a 
3.6 ± 1.5
ab 
1.5 ± 0.3
ab
 0.9 ± 0.2
b 
0.009 
Urinary P (final) (mg/7d) 30.3 ± 13.05
b
 52.7 ± 12.2
b
 29.2 ± 9.2
b
 149.2 ± 14.5
a
 18.5 ± 2.3
b
 22.38 ± 4.5
b
 <0.001 
Change in urinary pH (%) -1.28 ± 0.7
b
 0.48 ± 0.4
b
 -4.07 ± 4.3
b
 -9.79 ± 4.7
a
 -0.06 ± 0.07
b
 -0.29 ± 0.33
b
 <0.001 
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6.0 Results and conclusion 
Results presented here suggest that dietary components can have profound influence on 
renal health in female rats.  We found that changing the protein source (from casein to KPC) led 
to reduced NC and associated renal damage.  KPC contained residual lipid, which we described 
as being a unique ω-3 PUFA source in regards to lipid content.  To determine if the residual ω-3 
PUFA content was responsible for the observed benefits of KPC, we formulated casein-based 
diets that contained variable PUFA content.  To our surprise, the diet rich in the “pro-
inflammatory” ω-6 PUFAs did not result in NC.  Female rats fed krill oil developed NC, and this 
appeared to be due to the high PL (and subsequent high dietary P) content of the krill oil.  Aside 
from NC, changing the dietary PUFA content resulted in extreme variations in renal tissue PUFA 
composition.  In vitro studies have suggested that manipulating the PUFA content can modulate 
the activity of proinflammatory mediators such as PGE2, as well as proinflammatory signaling.  
Providing ω-3 PUFAs lead to reduced excretion of PGE2 and reduced expression of 
proinflammatory mediators.  Differences were also found among the dietary sources of ω-3 
PUFAs, in regards to both tissue PUFA content and elicited physiological responses. 
Therefore, we conclude that: 
1.) diet has a profound influence on renal health in non-diseased female rats,  
2.) changing the source of protein from casein to KPC influenced the development of 
NC in female rats, 
3.) krill oil has a unique lipid composition that is sensitive to processing methods, 
4.) PUFAs do not appear to modulate diet induced NC in female rats,  
5.) consumption of ω-3 PUFAs influences inflammatory signaling in non-diseased 
female rats, and 
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6.) lipid content and physiological responses varies among dietary ω-3 PUFA 
sources. 
The results presented here provide valuable information to the fields of nutrition, 
agriculture, physiology, and cell biology.  By understanding the interaction of diet and 
physiology, we can develop preventative measures to help decrease the prevalence of morbid 
diseases. 
 
